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Abstract
The radiosensitivity of the early developing human embryo is not well characterized. Radiation
protection guidelines in case of an in utero exposure are mainly based on animal experiments
and on epidemiological data. The mechanisms behind a radiation response of the embryo es-
pecially of high LET radiation is not completely understood. Therefore, there is a need to
elucidate the effects of low and high LET ionizing radiation on early embryonic development.
To contribute to a better understanding of this topic, H9 human embryonic stem cells were used
as an in vitro tool to investigate the early blastocyst-like stage of the human embryonic develop-
ment. As the latter give rise to an entire functional organism, maintaining their structural and
genomic integrity is mandatory to avoid passing DNA damage on to the progeny. In the litera-
ture, it is reported that embryonic stem cells indeed exhibit a lower mutation frequency and that
they show a higher apoptotic activity upon DNA damage, compared to differentiated somatic
cells. A previous study on mouse embryonic stem cells performed at GSI indicates that even
though eighth generation daughter cells still harbor chromosomal aberrations after exposure to
high LET radiation, they are capable to maintain a pluripotent cell population.
This study elucidates the capacity of human embryonic stem cells to efficiently eliminate dam-
aged cells upon ionizing radiation exposure and to proceed normally into endoderm differenti-
ation. Thus, human embryonic stem cells were exposed to 1 and 3Gy of X-rays, as well as to
1Gy and 3Gy of high LET radiation i.e. C, Ca, Ni and Ti ions. Human embryonic stem cells
were observed up to 14 days after exposure in pluripotency maintaining culture conditions, and
up to 11 days in conditions promoting differentiation into definitive endoderm. Endpoints such
as cell cycle block, apoptosis, chromosomal aberrations, and gene expression related to embry-
onic signaling pathways and pluripotency as well as differentiation were investigated. It was
found that isodoses of high LET radiation were more effective than X-rays in inducing apop-
tosis and chromosomal aberrations in human embryonic stem cells. After a radiation induced
G2 block, a fraction of cells undergoes apoptosis. However, few stable chromosomal aberra-
tions are still found in the progeny of exposed human embryonic stem cells. Gene expression
studies of embryonic signaling pathways showed a majority of downregulated genes related to
WNT, FGF, Hedgehog, TGFβ and Notch signaling pathways. These signaling alterations presum-
ably cause the observed downregulation of core pluripotency markers like OCT4A and NANOG.
Consequently, differentiation capability into definitive endoderm was impaired.
Together, the results reported in this work might indicate several consequences for the early
embryo in case of an in utero exposure, like implantation failure due to cell cycle arrest and
apoptosis, or malformations due to alterations in cell signaling and differentiation processes.
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Zusammenfassung
Die Empfindlichkeit des frühen Embryos auf ionisierende Strahlung ist nicht ausreichend cha-
rakterisiert. Richtlinien des Strahlenschutzes bezüglich einer in utero Bestrahlung basieren
hauptsächlich auf Tierexperimenten sowie epidemiologischen Studien. Die Mechanismen, die
einer Strahlenantwort des Embryos zu Grunde liegen, sind besonders im Fall von Hoch-LET
Strahlung nicht vollständig geklärt. Um zu einem besseren Verständnis über die Wirkung ioni-
sierender Strahlung auf die frühe embryonale Entwicklung beizutragen, wurden H9 embryonale
Stammzellen als in vitroModell für das Blastozysten-Stadium des frühen Embryos eingesetzt. Da
die embryonalen Stammzellen in diesem Entwicklungsstadium die Grundlage für einen vollstän-
dig funktionalen Organismus darstellen, und um zu verhindern, dass mögliche DNA Schäden
an Tochterzellen weitergegeben werden, ist eine Aufrechterhaltung der genomischen Integrität
notwendig. Tatsächlich wurde in der Literatur bereits eine geringere Mutationsrate in embryo-
nalen Stammzellen sowie eine hohe Apoptoserate in Folge von DNA Schäden im Vergleich zu
differenzierten Zellen beschrieben. In einer zuvor an der GSI durchgeführten Studie konnte be-
obachtet werden, dass Nachkommen von Hoch-LET bestrahlten embryonalen Stammzellen der
Maus Chromosomenaberrationen aufweisen. Die Ergebnisse in Bezug auf das Pluripotenzsta-
dium weisen aber darauf hin, dass die Zellen in der Lage sind, dieses aufrechtzuerhalten.
In dieser Arbeit wurde die Fähigkeit von humanen embryonalen Stammzellen untersucht,
durch ionisierende Strahlung geschädigte Zellen von der pluripotenten Population zu entfernen
um somit die Differenzierungseigenschaften in definitives Entoderm aufrechterhalten zu kön-
nen. Dazu wurden Bestrahlungsexperimente mit 1 und 3 Gy Röntgenstrahlen, als auch mit 1
und 3Gy Schwerionen-Strahlung (C, Ca, Ni und Ti Ionen) durchgeführt. Die Zellen wurden
zum einen unter Pluripotenz-erhaltenden Bedingungen bis zu 14 Tage, als auch 11 Tage lang
unter Bedingungen, die die Differenzierung in definitives Entoderm fördern, beobachtet. Dabei
wurden Endpunkte wie Zellzyklus-Arrest, Apoptose, chromosomale Aberrationen und Genex-
pression in Bezug auf embryonale Signalwege, Pluripotenz und Differenzierung untersucht.
Die Ergebnisse der Apoptose-Messung sowie der Untersuchung von chromosomalen Aberra-
tionen zeigten eine höhere biologische Wirksamkeit von Hoch-LET im Vergleich zu Niedrig-LET
Strahlung in humanen embryonalen Stammzellen. Es wurde zudem ein strahleninduzierter G2
Zellzyklus-Arrest beobachtet. Obwohl ein Teil der geschädigten Zellen in Apoptose ging, traten
auch in den Tochterzellen noch chromosomale Aberrationen auf. Untersuchungen der Genex-
pression infolge von Bestrahlung zeigten eine Herabregulation von embryonalen Signalwegen
wie WNT, FGF, Hedgehog, TGFβ und Notch, was vermutlich auch für die beobachtete Herabre-
gulation der Expression von Pluripotenzmarkern wie OCT4A und NANOG verantwortlich ist. In
der Folge war auch die Differenzierung zu definitivem Entoderm im Vergleich zu unbestrahlten
Zellen beeinträchtigt.
Zusammenfassend weisen die Ergebnisse dieser Arbeit im Falle einer in utero Bestrahlung
darauf hin, dass es auf Grund von Zellzyklus-Arrest und Apoptose zu einer Nidationsstörung
und Frühabort kommen kann, und dass auf Grund von Veränderungen in Signalwegen und
Differenzierungsprozessen Missbildungen möglich sind.
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1 Introduction
1.1 Human exposure to ionizing radiation
Human beings, like every other living organism on earth, are constantly exposed to ionizing
radiation (IR) with a mean dose of 4mSv/year (reviewed in [1]). This background radiation
results from natural sources, e.g. cosmic radiation (0.3mSv/year) or to a greater extend from
the decay of inhalated radon gas (0.4mSv/year), and from man-made sources that mainly com-
prise diagnostic and therapeutic medical procedures (1,9mSv/year). Furthermore, accidents in
atomic power plants or radio-terrorism could be conceivable scenarios, in which a person ab-
sorbs an additional dose of IR. These exposure scenarios can as well affect the unborn embryo
(see also section 1.7), even though law and security guidelines restrict the medical and occu-
pational exposure of an expectant mother. These laws and guidelines can only work effectively
if the pregnancy is already noted. However, especially in the very early phase of gestation, the
mother-to-be is often not yet aware of being pregnant. Possible scenarios of an in utero expo-
sure comprise occupational exposures like pregnant aircraft personnel being exposed to cosmic
radiation, diagnostic imaging techniques like computer assisted tomography (CT), or ion radio-
therapy. The dose of a medical procedure using IR depends on many factors like the region of
interest, the size of the patient, or the number of scans performed. The number of medical imag-
ing procedures pregnant patients undergo has increased by 121% from 1997 to 2006 [2]. For
instance, for an abdominal CT scan an average dose of 10mSv for the patient [3] and 25mGy
for the conceptus [4] is estimated. An example for a therapeutic exposure of a pregnant woman
is reported in a case study about a patient who’s skull-base chordoma was treated with carbon
ion therapy at GSI, Darmstadt [5]. The patient got aware of the pregnancy after six fractions of
a total treatment of 60 GyE (isoeffective photon dose) to the tumor in 20 fractions. Expecting
a low dose to the uterus based on water phantom calculations, the treatment was continued.
Additional active and passive dosimetry was used to monitor the dose received by the pelvis,
revealing a total dose of 82µSv. The dose in the uterus was estimated as <0.2mSV. The child
was born without any malformations and normal development was recorded up to the age of
one year.
Besides the medical scenarios, a better understanding of the effect of IR on the embryonic
development is also important for determining correct occupational dose limits for pregnant
workers. In Germany, the dose limit for the embryo during the entire gestation period (from
the moment when the women officially declares being pregnant to delivery) is 1mSv according
to §55 of the Radiation Protection Ordinance [6]. Risk estimates and dose limits are mainly
derived based on epidemiological data from atomic bomb survivors, and often supported by
animal studies. Consequences from IR exposure for the embryo range from deterministic effects
(meaning an effect bearing a threshold dose) like embryonic death, congenital malformations,
low birth weight, neurobehavioral effects to stochastic effects (no threshold dose) namely child-
hood cancer (see figure 1.1; reviewed in [2]). The risk of a certain consequence depends on the
gestation period. The pre-implantation phase (up to two weeks post conception) is also known
as the all-or-nothing-phase of gestation. In this early phase, the embryo either survives without
any other defects or the exposure results in embryonic death depending on whether adjacent
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cells are able to replace the IR affected cells or not. In this period, the threshold dose of 0.1Gy
for embryonic death is fairly low and increases with the duration of the pregnancy. During
organogenesis (two to seven weeks), IR affected cells are not replaced as easily anymore as in
earlier developmental periods. Therefore, the most likely results are congenital malformations
and growth retardations with a threshold dose of 0.3Gy. From week 8 to week 15, data from
atomic bomb survivors being exposed in utero show that neurobehavioral effects occurring with
a threshold dose of 0.3Gy are the most frequent consequences in this developmental phase.
These effects include microcephaly and a loss of approximately 30 points of IQ per Gy. Further-
more, a correlation between childhood cancer and in utero exposure exists, but the sensitivity
during the gestation period is controversially discussed. For example, none of the atomic bomb
survivors exposed in utero developed leukemia [7]. The recommendation of the NCRP [8] and
the ICRP [9] state that there is no increased probability for non-cancerous effects below a dose
of 0.05Gy, which is below the dose of most diagnostic medical procedures.
Still, the effects of IR on the early embryonic development raise many questions related to the
radiation risk, consequences of exposure and the underlying biological mechanisms, that also
depend on the physical characteristics of IR (overview in [10] and [11]).
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Figure 1.1: Consequences resulting from IR exposure in utero. Three dose ranges (<0.05Gy, 0.05 to 0.5Gy and
>0.5Gy) are evaluated over the three developmental periods, i.e. blastogenesis (also known as pre-implantation
phase), organogenesis and fetogenesis. From [2].
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1.2 Physical characteristics of ionizing radiation
Radiation is termed ionizing, if its energy exceeds the amount needed to eject a single electron
from and therefore ionize a target atom. For accelerated particles, the energy exceeds this
threshold (see also table 2.1 for energies used in this work). The dose (D) delivered by IR in a
target is defined as the energy absorbed (∆E) per mass unit (m) in Gray (Gy):
D =
∆E
m
(1.1)
The absorbed dose multiplied with a radiation weighting factor (WR) is defined as the radia-
tion weighted dose or equivalent dose (H) in Sievert (Sv):
H = D ·WR (1.2)
A microscopic view on the process of dose deposition in the target reveals different ways of
interaction of IR with matter. X-rays and γ-rays are called sparsely IR. They interact mainly via
Compton and photoelectric processes. Particles like heavy ions are densely ionizing and mainly
interact via Compton and nuclear interactions. Thus, the resulting dose distribution pattern of
sparsely IR is rather homogeneous, while densely IR reveals a heterogeneous dose distribution
pattern (see figure 1.2A). The shown pattern of carbon ions for instance exhibits local dose
maxima and areas without any dose deposited. As a result, few cells might receive a fairly high
dose, while other cells in the same target sample do not receive any dose at all. With increasing
energy of the particle radiation, the number of local dose maxima (as well as the particle range,
see figure 1.2B) increases. The different microscopic dose distribution patterns eventually lead
to a different biological effect when comparing isodoses of different radiation qualities. For
example, an exposure to 2Gy carbon ions results in a much stronger biological effect than an
exposure to 2Gy X-rays. As a measure for this difference, the Relative Biological Effectiveness
(RBE) is defined as the ratio of the dose of a reference exposure (Dref) to the dose of a certain
exposure (Dtest) for the same effect, also expressed as:
RBE =
Dre f
Dtest
(1.3)
With increasing mass of the particle and with decreasing velocity, the number of ionization
events along the particle track, and accordingly the energy deposited along the particle track
increases. The energy transferred to the target (dE) per unit length of the track (dx) is defined
as the linear energy transfer (LET):
LET =
dE
dx
(1.4)
A macroscopic view of the interactions of IR is shown in figure 1.2B, where the dose deposition
is illustrated as a function of the depth. The dose deposited by photons shows an initial maxi-
mum caused by the buildup effect, which then continuously declines with increasing depth. In
contrast, particles show an inverted dose profile, meaning that its dose deposition is very low in
the beginning and exhibits a sharp peak (also known as Bragg peak) near the end of its pene-
tration depth. This is an important characteristic for heavy ion therapy, where the normal tissue
surrounding a tumor is spared owing to the physical characteristics of particles resulting in the
inverted dose profile. By changing the energy of the particles, the range of the particles can be
adapted to a certain position in the tissue.
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Figure 1.2: A: Dose deposition pattern of sparsely ionizing X-rays (upper left panel) and of densely ionizing particle
radiation with three different energies, ranging from 1MeV/u (upper right panel) to 15MeV/u (lower left panel)
and 200MeV/u (lower right panel). While X-rays deposit a homogeneous dose in the target, densely ionizing
particles show a heterogeneous dose deposition pattern with local dose maxima. The higher the energy of the
particle, the lower the local dose of a single dose maximum (corresponding to the height of a local dose peak).
Consequently, more local dose maxima with a lower local dose in case of 200 MeV/u result in the same total dose
of 2 Gy as do fewer local dose maxima with higher local dose in case of 15 MeV/u. B: Depth dose profile of sparsely
ionizing photons and of densely ionizing carbon ions with three different energies (100MeV/u, 200MeV/u and
300MeV/u). While the dose of photons first exhibits a buildup region and then continuously decreases with depth,
the dose of particle radiation shows the typical Bragg peak, describing a dose peak at a certain penetration depth
that depends on the energy of the particle. A and B both from [11].
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1.3 DNA damage and its relation to the cell cycle
Revisiting the microscopic view, the most radiosensitive target in the cell is the DNA. It can be
damaged directly or indirectly by IR (reviewed in [11]). For example, an atom in the DNA
molecule can be directly hit and ionized, which most likely happens in case of high LET radia-
tion. Low LET IR is more likely to first hit another molecule like water, therefore producing a
secondary electron (also known as delta electrons), which in turn hits the DNA. These events
can lead to different types of DNA damage such as single strand breaks (SSBs) or double strand
breaks (DSBs). SSBs can be repaired more easily, while the consequences of DSBs are more
severe. In case of high LET IR, clustered DSBs and SSBs occur more likely compared to low LET
IR due to the high local ionization density. This complex DNA damage is even more difficult to
repair, and can lead to cell death, mutations and genetic instability.
Not only the radiosensitivity but also the resulting consequences of radiation induced DSBs are
directly connected with the cell cycle phases [12]. Normally, the cell is cycling through a grow-
ing phase named G1, a DNA synthesis phase named S, and a second growing phase named G2
followed by mitosis (also known as M phase). Once the DNA damage is induced, the cell can
arrest at different cell cycle checkpoints in order to repair the damage (for more details on the
cell cycle in pluripotent stem cells, refer to section 1.5.3 and 1.5.4) before continuing with pro-
liferation. Cells in S phase are the least radiosensitive ones due to the open chromatin structure
during replication that is easily accessible for repair proteins, followed by cells in G1 phase. The
most radiosensitive cell cycle phases are the G2 and the M phase, due to the double amount
of the most sensitive target for radiation, the DNA, and due to its very compact state. Also,
which DNA repair mechanism is chosen depends on cell cycle phases. In G1 phase, the error
prone non-homologous end joining (NHEJ) is the most prominent repair mechanism, while in
G2 phase, the homologous sister chromatid can be used to repair damage via the high fidelity
homologous recombination (HR) in addition to NHEJ [13].
1.4 Chromosome aberrations
Depending on their severity, lesions are not necessarily repaired completely. Instead, DNA can be
rejoined, stay unrejoined or even rejoin incorrectly. Different chromosome staining techniques
were developed like G-banding, Giemsa staining, multicolor Fluorescence In Situ Hybridization
(mFISH) etc. to detect such lesions and their resulting chromosome aberrations and each tech-
nique contains its advantages and disadvantages. They differ in the resolution of detectable
chromosomal changes and in their potential of revealing different types of aberrations. For ex-
ample, reciprocal translocations can be detected in mFISH, but not with Giemsa staining. The
classification of mFISH stained chromosome and chromatid aberrations used in this study is
based on the, even though much more complex, classifications defined by M. N. Cornforth [14].
Chromatid aberrations do result from breaks that are produced when already two sister chro-
matids are present like in G2 phase, while chromosome aberrations result from breaks induced
when only one chromatid is present and the damage can be replicated, like in G1 phase. Based
on the number of breaks induced, on the number of chromosomes involved, and on the type of
rejoining (symmetrically or asymmetrically), one can define further classifications of aberrations
(see figure 1.3). Transmissible aberrations like reciprocal translocations are considered to be po-
tentially carcinogenic or lead to genomic instability. Non-transmissible aberrations like rings and
dicentrics often lead to anaphase bridges during mitosis, and truncated chromosomes with acen-
tric fragments lead to intolerable genetic loss. Complex aberrations are non-transmissible if they
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comprise a ring or a dicentric. The spectrum of radiation induced aberrations depends on the
radiation quality. For example, complex chromosome aberrations can be observed more likely
in cells exposed to densely IR than exposed to sparsely IR due to their different microscopic
dose distribution patterns. The quantity of radiation induced chromosome aberrations depends
on the absorbed dose in a linear-quadratic manner, as well as on the radiation quality. There-
fore, chromosome aberrations such as easily detectable dicentrics are often used for biological
dosimetry [15].
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Figure 1.3: Classification
of chromosome aberrations,
showing the origin of DNA
lesions with lines indicating
the lesion, and the involved
chromosomes (left) as well
as the resulting aberrations
(right).
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1.5 Stem cells
The term “stem cells” first appeared in scientific literature in 1886. It was the German scien-
tist Ernst Haeckel who used this term to describe a fertilized egg from which the three germ
layers originate [16, 17]. Only a few years after, A. Weismann published his work in which he
found that neither acquired characteristics can be inherited, nor are characteristics inherited
by somatic cells, but by germ cells [18, 19]. At the same time, H. Driesch, a former student
of Haeckel and Weismann, studied the embryonic development in sea urchins. He found that,
when separated at the four-cell-stage, each single cell was able to develop an entire larvae. This
finding was remarkable, because he expected that only the corresponding quarter of the larvae
would develop. With this experiments, he found the concept of totipotency, the ability of a single
cell to develop an entire organism. The first embryonic stem cells (ESCs) cultured in vitro were
isolated from mouse blastocysts in 1981 by M. J. Evans (who won the Nobel Prize for Physiology
and Medicine in 2007 [20]) and M. H. Kaufman [21], and in parallel by G. R. Martin [22]. Such
cells are capable to form all cell types of the embryo. But as they lack the capacity to form tissue
arising from the trophoblast, no living individual can develop from these cells, which are termed
pluripotent (see also section 1.5.1). In 1998, James A. Thomson for the first time succeeded in
deriving human embryonic stem cells (hESCs) and culturing them in vitro [23]. However, iso-
lating hESCs requires the destruction of embryos, which in case of human embryos is a subject
of ethical debate (see also section1.5.1). Therefore, it was an important step to resolve this
issue when in 2007 Shinya Yamanaka published that it is possible to reprogram adult human
fibroblasts into pluripotent cells [24]. Today we know that there are still important differences
between these induced pluripotent stem cells (iPSCs) and ESCs like epigenetic background or
genetic stability [25]. However, this finding was of tremendous importance, because it changed
the dogma of unidirectional differentiation, and it provided the basis for investigating diseases
in patient derived iPSC. Eventually, Yamanaka together with John B. Gurdon received the Nobel
Prize in 2012 “for the discovery that mature cells can be reprogrammed to become pluripotent”
[26].
Besides pluripotent stem cells, different levels of cell potency are known. The zygote for example
is described as being totipotent, meaning that it can still generate a whole organism including
all extraembryonic tissues needed for its complete development. An example for multipotent
adult stem cells are hematopoietic stem cells. They are more restricted in their differentiation
potential than pluripotent stem cells, since they can give rise only to a subgroup of cells, like
the different blood cell types. A much lower level in cell potency can be described by unipotent
cells, which are able to differentiate only into one cell type (reviewed in [27]).
1.5.1 Embryonic stem cells
The two main characteristics of ESCs are their potential to differentiate into every cell type of
an organism also known as pluripotency, as well as their ability for infinite self-renewal. Thanks
to these special traits, hESCs represent the most suited in vitro tool available to understand
early mechanisms of human embryonic development [28]. hESCs are derived from the inner
cell mass (ICM) of blastocysts. These are about five days old pre-implantation embryos that
consist of an outer cell layer named trophoblast, which later will give rise to extraembryonic
tissues, and the ICM from which the organism will originate (for more information on embryo-
genesis, see section 1.6). By isolating cells from the ICM and culturing them in vitro, hESC lines
can be established. However, it is discussed in literature that hESCs isolated from the ICM are
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considered primed pluripotent instead of naive pluripotent, since hESCs resemble more mouse
epiblast stem cells than mouse ESCs [29]. It is suggested that from the isolation of the ICM to
the establishment of the hESC cell line, the cells might continue some developmental steps and
might thus more closely resemble the epiblast [30].
The fact that hESCs are derived from early human embryos automatically introduces ethical
concerns. The potential implications of hESCs for regenerative medicine, toxicity testing, and
studies of the early embryonic development etc, have to be weighted up against the inevitable
destruction of the embryo during hESC derivation. In Germany, the Stem Cell Act of June
14, 2008 (StzG) [31] together with the Act for Protection of Embryos of October 23, 2001
(ESchG) [32] provide the legal basis for the research on hESCs. To prevent that human em-
bryos are created for any other reason than reproduction, the act allows research on hESCs
only in very limited cases. The research must be of high interest for basic research or for
potential medical use and it must be justified that this research cannot be performed with
any other means, for example mouse ESCs or iPSCs. Furthermore, it is only allowed to im-
port hESCs, that are established before May 1, 2007. An application for the import and the
use of hESCs has to be submitted to the Robert-Koch-Institute, that further asks the Central
Ethics Commission on Stem Cell Research for its opinion and eventually approves or rejects
the application. To date, 99 applications are granted for the scientific use of hESCs in Ger-
many (www.rki.de/DE/Content/Gesund/Stammzellen/Register/register_node.html, as of Jan-
uary 2015).
1.5.2 Pluripotency network in hESCs
Our understanding of pluripotency is mainly based on studies in mouse ESCs. However, since
pluripotency differs in its mechanisms between mouse and human ESCs [33], I want to empha-
size that this section mainly deals with the mechanisms responsible for pluripotency in human
ESCs as long as species-specific data is available. Pluripotency is established and maintained by
a huge interactive network comprising many different players, for example embryonic signaling
pathways that process mainly external signals, miRNAs inhibiting the translation of proteins
involved in differentiation, chromatin structure and its remodeling factors, epigenetic modifica-
tions and the core transcription factors namely OCT4, NANOG and SOX2 (reviewed in [34]).
All these many players not only act autonomously, but interact in a complex manner with each
other. Additionally, many interactions, targets or effects are not yet elucidated, and those mech-
anisms investigated for a certain hESC line are not necessarily acting in the same manner in
another hESC line. Thus, understanding the pluripotency network is still a challenging subject
in ESC research. Due to the experimental focus of this work, the main signaling pathways like
TGFβ signaling, FGF signaling, WNT signaling as well as the core transcription factors and their
mechanisms will be explained in the following sections.
TGFβ signaling
Besides the TGFβ superfamily members like TGFβ, NODAL, GDFs and BMPs, Activin is the
mostly used TGFβ receptor ligand to maintain the pluripotent state of hESCs in vitro. Bind-
ing of Activin (see figure 1.4A) leads to the formation of a heterotetramer composed of two
type I and two type II serin/threonin kinase receptors. Downstream of the canonical Activin
signaling, SMAD2 and SMAD3 are phosphorylated and then act together with SMAD4 as a
transcription factor complex activating the expression of NANOG. At the same time, Activin sig-
naling also leads to an inhibition of BMP4, which otherwise would activate SMAD1, SMAD5 and
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Figure 1.4: The pluripotency network as described in section 1.5.2 is composed of many interacting pathways. A
shows the TGFβ signaling pathway adapted from [35], B shows the FGF signaling pathway with its four downstream
pathways JAK/STAT, PLCγ, PI3K and the MEK/ERK from [36], and C shows the canonical WNT signaling pathway
adapted from [37].
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SMAD8 and therefore inhibit the expression of NANOG. In short, Activin signaling preserves the
pluripotent state of the cell and simultaneously inhibits the expression of factors leading to dif-
ferentiation (overview in [35, 38]). The effect of Activin on hESCs is concentration dependent.
Lower concentrations of Activin, such as 5 to 10 ng/ml, are sufficient to maintain pluripotency
[39]. In contrast, increasing the dose of Activin to 100ng/ml in the culture medium induces
differentiation into definitive endoderm [40, 41].
FGF signaling
Even though it is known that the main ligand of FGF signaling for the in vitro culture of
hESCs, FGF2, plays a major role in the maintenance of pluripotency [42], the exact mechanisms
are still not understood in detail. However, it is widely accepted that FGF2 acts via several
intracellular and indirect extracellular mechanisms (see figure 1.4B). The latter comprises the
induction of feeder cells secreting TGFβ and Activin A. These in turn lead to the activation
of NANOG expression in hESCs via intracellular SMAD2/3 signaling. The direct intracellular
mechanisms of FGF2 all require its binding to one of the four FGF receptor isoforms (FGFR1-4).
For the binding, heparan sulfate proteoglycans are important due to their co-receptor function,
but they are also necessary for the regulation of the FGF2 bio-availability. As a consequence,
FGFRs dimerize and four possible downstream pathways can be activated. These comprise
the JAK/STAT, PLCγ, PI3K and the MEK/ERK pathway [36]. Additionally, these downstream
signaling pathways do also perform a complicate crosstalk among each other. However, the
JAK/STAT pathway plays a bigger role for pluripotency in mouse than in human ESCs. The PLCγ
pathway leads to the activation of protein kinase Cδ as well as to Ca2+ release from intracellular
storages. The PI3K pathway leads to the inhibition of differentiation via Akt, as well as together
with Activin/SMAD to a maintenance of pluripotency and self renewal [43, 44]. This pathway
is also adressed by Knockout Serum Replacement [45], a common medium component in hESC
culture. The most important MEK/ERK pathway acts via H-RAS and eventually leads to the
activation of ERK2 and ELK1, which as transcription factors inhibit the expression of genes
involved in differentiation and support pluripotency and self-renewal [46]. In addition to these
four classical signaling pathways, it was also found that FGF2 has an anti-apoptotic function in
which it prevents caspase-mediated anoikis, a subtype of apoptosis induced by the detachment
of the cell from its extracellular matrix [47].
WNT signaling
WNT signaling (reviewed in [48, 37]) can occur via different pathways. Thus, this section will
focus on the canonical WNT/β-catenin signaling pathway (see figure 1.4C). In the absence of the
WNT ligand, β-catenin located in the cytosol of the hESC forms a complex with Axin, GSK3β and
APC. β-catenin is then phosphorylated and polyubiquinated and can therefore be recognized
to be degraded by proteasomes. In contrast, if WNT ligand is present, it interacts with its
receptor Frizzled as well as the co-receptor LRP5/6 whereby three different pathways can be
activated. These comprise WNT/JAK, WNT/Ca2+ and the canonical WNT/β-Catenin, the latter
being described as the most important for hESC maintenance among the three pathways (see
also figure 1.4C). Subsequently, the protein Dishevelled is phosphorylated and translocates to
Frizelled, where LRP5/6 is phosphorylated by CK1 and GSK3β. Then, Axin is recruited by
LRP5/6 disrupting the degradation of β-Catenin. As a consequence, β-Catenin accumulates
in the cytoplasm and enters the nucleus where it can interact with members of the TCF/LEF
family (LEF1, TCF1, TCF3 and TCF4), especially with TCF3. Consequently, the effect of TCF3 is
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Figure 1.5: The core pluripotency transcription fac-
tors OCT4, SOX2 and NANOG can either activate or si-
lence many target genes that either support pluripo-
tency or differentiation, respectively. The lower left
panel shows the autoregulatory feedback loop be-
tween OCT4, SOX2 and NANOG. For more details see
section 1.5.2. From [27].
annihilated and its targets like SOX2, NANOG and POU5F1 as well as many common targets of
OCT4 are not repressed anymore. In short, β-Catenin is degraded in the absence of WNT, while
it accumulates and then targets gene regulatory regions together with TCF3 in the presence
of WNT. However, the effect of WNT signaling depends on the interplay with other extrinsic
factors. In the presence of FGF2 and Activin, WNT signaling supports self-renewal, while in
the absence of FGF2 and Activin, WNT signaling supports differentiation towards endo- and
mesoderm [49].
Core pluripotency transcription factors: OCT4, SOX2 and NANOG
The main transcription factors associated with pluripotency like OCT4, SOX2, NANOG are
known as core transcription factors of pluripotency (reviewed in [50–52]).
The Octamer binding transcription factor 4 (also known as OCT3, OCT4 or OCT3/4) belongs to
the class V POU family of transcription factors and is encoded by the POU5F1 gene. It consists of
a POU-specific domain POUS and a POU homeodomain POUHD connected with a linker region,
both of them operating as DNA-binding motives. In hESCs, three different isoforms of OCT4 are
known, among which OCT4A is related to pluripotency, and OCT4B and OCT4B1 are related
to cell stress response [53]. OCT4A does not only function as a transcription factor but also
interacts with chromatin remodeling factors or factors involved in DNA replication and repair
(reviewed in [50]).
NANOG, another homeobox domain protein, occurs in two isoforms. It consists of three domains
being an N-terminal domain, a homeodomain and C-terminal domain, which is functionally the
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most dominant. It can directly be bound and upregulated by SMAD2 and SMAD3 [54].
OCT4, NANOG and SOX2 (SRY (sex determining region Y)-box 2) are all highly conserved
within their protein families, as well as evolutionary conserved in mammals. They are found
in the pre-implantation embryo as well as in many cancers. They bind not only as a single
transcription factor to many downstream target genes, but also act co-operatively as transcrip-
tion factor complexes. In ChIP-Chip studies, Boyer and colleagues found that OCT4, NANOG
and SOX2 occupied 404 genes simultaneously [55]. It is further known that the three factors
not only regulate downstream targets, but form auto regulatory positive and negative feedback
loops to regulate their own expressions (see figure 1.5). Furthermore, besides promoting the
expression of genes that are important for the pluripotent state, they are also found to occupy
genes that are important for differentiation, thus silencing them in cooperation with the repres-
sive function of PcG proteins [50]. OCT4 for example was found to inhibit definitive endoderm
differentiation. Already slight variations in their protein concentration can change their func-
tion from maintaining pluripotency and subsequently leading to differentiation. OCT4, NANOG
and SOX2 also play an important role in reprogramming of somatic cells into iPSCs. Different
approaches of cell reprogramming involve the increase of expression of various sets of genes.
For example, Yamanaka and colleagues used the four transcription factors OCT4, SOX2, C-MYC,
and KLF4, also known as the Yamanka factors, to reprogram mouse embryonic fibroblasts into
induced pluripotent stem cells [56].
1.5.3 Unique properties of hESCs
Besides pluripotency and infinite self-renewal, hESCs possess additional properties in which
they differ from adult somatic cells. All these properties comprise a network that ensures the
maintenance of the pluripotent state and genomic integrity.
Anaerobic metabolism
In the pre-implantation embryo, no mitochondrial biogenesis takes place in the anyway hy-
poxic environment (1,5-9% in vivo [57]), leading to a very low number of immature mitochon-
dria [58]. Consequently, the main metabolic pathway used in hESCs is anaerobic glycolysis,
which is independent of mitochondria, shifting towards oxidative phosphorylation when dif-
ferentiating (reviewed in [59]). The low number of mitochondria implies a low production of
reactive oxygen species (ROS), and additionally hESCs posses the capacity to remove ROS by
high levels of antioxidant enzymes. Since ROS are known to induce endogenous DNA dam-
age and enhance differentiation of ESCs, the metabolic characteristics of hESCs help to protect
their genomic integrity and pluripotent state. hESCs also exhibit a high metabolism rate, which
causes a high uptake rate of medium components and the need for daily medium exchanges in
in vitro cell cultures.
Abbreviated cell cycle
hESCs cultured in vitro possess a relatively short cell cycle with a duration of approximately
16-20 h, of which 65% are attributed to S phase and only 15% each are attributed to the very
short gap phases [60, 61]. The relatively long S phase implicates a long period that hESCs
spend to replicate their DNA, making them more prone to replication-induced DSBs compared
to differentiated somatic cells [62]. However, the duration of the cell cycle can vary by 25%
depending on the passage number [63]. The G1 phase is especially interesting in relation to
pluripotency. That part of the cell cycle is characteristically short in ESCs compared to differ-
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entiated somatic cells, due to mitogen-independent proliferation. The transition through the
different cell cycle phases is controlled by a system of cyclin dependent kinases (CDKs) and cy-
clines. CDK2 plays a crucial role in G1/S- transition, and it has been shown that downregulation
of CDK2, for example as a consequence of DNA damage, induces cell cycle arrest and apopto-
sis, interferes with DNA replication and repair, and leads to differentiation [64, 65]. CDKs and
cyclins are also regulated by transcription factors like OCT4, SOX2 and NANOG, connecting the
pluripotency network directly with cell cycle progression. The exact mechanisms behind the
abbreviated G1 phase and its connection to pluripotency are not yet elucidated. However, re-
programmed iPSCs also show an abbreviated G1 phase, and differentiation of pluripotent cells
is initiated in G1 phase [66]. A short G1 phase limits the time frame for receiving differentiation
signals and therefore supports the pluripotency state [67].
Maintenance of genetic stability
Even though it is reported that early embryos in the cleavage state exhibit a high rate in ane-
uploidy and genome instability [68], in vitro cultured hESCs mostly reveal a normal diploid
karyotype. Compared to differentiated somatic cells, ESCs even show a lower mutation fre-
quency [69]. Studies that are reporting karyotypic abnormalities in hESCs are mostly related to
culture conditions like enzymatic or manual passaging, the number of freezing cycles and the
passage number, the media composition, the mouse embryonic fibroblast (MEF) feeder line as
well as the oxygen pressure (reviewed in [70]). The biggest consensus in this highly debated
field of karyotypic abnormalities is its correlation with culture conditions and passaging number.
It is also the most likely factor given that most karyotypic alterations appear due to a growth
advantage of a cell harboring a certain abnormality, that can overgrow the culture with time
and increasing passage numbers.
A study by the International Stem Cell Initiative investigated genetic changes in hESC lines
from world wide laboratories, and they found abnormal karyotypes in 34% of the 125 cell lines
investigated [61]. These aberrations mostly comprise gains of the total chromosomes or dupli-
cation of segments of 1, 12, 17, 20 (20q11.21 being the most prominent) or X [70], or losses
of chromosome segments 10p13-pter, 18q21-qter and 22q13-qter. A significantly higher frac-
tion of long-term cultures (33%) showed karyotypic alterations in comparison to early passages
(14%). Also, they found a correlation of abnormal karyotypes and passaging technique, namely
a significant higher fraction of karyotypic alterations in cells passaged enzymatically than in cells
passaged manually. The reasons of specific, recurrent karyotypic alterations are not understood
in detail. However, the loci of genes that might be responsible for a growth advantage were lo-
cated among the set of chromosomes commonly observed as trisomies or duplicated segments.
For example, a potential explanation for a correlation of a growth advantage and the gain of
chromosome 20 is the location of genes for the BCL2L1, DNMT3B, ID1 [70] and miR-1825 on
this particular chromosome in segment 20q11.21. The product of BCL2L1 has an anti-apoptotic
function, DNMT3B is pluripotency-associated, the expression of ID1 is self-renewal promoting,
and miR-1825 is discussed to potentially inhibit more than 400 targets that could be involved
in suppression of apoptosis and in cell growth [71]. Furthermore, the gene for self-renewal
promoting NANOG as well as its pseudogene NANOGP1 that might act as competing miRNA
targets is located on chromosome 12, giving a hint to explain the growth advantage in case of
trisomy 12 or gain of chromosome 12 [61]. Noteworthy, hESC specific karyotypic alterations are
also observed in cancer cells, raising the question whether hESCs might harbor a tumorigenic
potential [71].
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Facilitated cell death
To further protect their genome, hESCs are capable to undergo apoptosis more easily and
rapidly than differentiated somatic cells [72]. A study performed by Dumitru and colleagues
revealed a mechanism based on constitutively active BAX that is responsible for the facilitated
apoptosis in hESCs [73]. In differentiated somatic cells, BAX exists in complex with KU70,
which keeps it in its inactive form. Upon apoptotic stimuli, KU70 becomes acetylated, and BAX
becomes activated, translocates into the mitochondria where it induces CytochromeC release
and consequently activation of Caspase cascades. In contrast, KU70 in hESCs is already acety-
lated under normal circumstances, and BAX is constitutively available in its active form. Upon
apoptotic stimuli, it can easily translocate in a p53 dependent manner to the mitochondria [74].
Thus, apoptosis is induced much faster than in differentiated somatic cells. These findings are
supported by a study of Liu and colleagues, in which they report that hESCs are in a mito-
chondrial primed state, which predisposes them to apoptosis [75]. More detailed, they found
elevated mRNA levels of pro-apoptotic PUMA and lowered mRNA levels of the anti-apoptotic
BCL2 in hESCs compared to differentiated somatic cells. Furthermore, Wang et al. found that
adherent hESCs undergo a subtype of apoptosis, namely anoikis, to balance cell density in in
vitro cultures [47]. Anoikis is a form of programmed cell death induced by detachment of the
cell from its extracellular matrix [76].
1.5.4 Response of hESCs to IR: state of the art
IR induced DNA damage response (DDR) of hESCs has been investigated in the past years
mainly with a focus on sparsely IR like X-rays and γ-rays [77–80].
Most studies investigating the influence of IR on cell cycle progression report that hESCs do
not undergo a cell cycle checkpoint in G1 phase, but in G2 phase [79, 78, 66]. A G1/S check-
point was only observed in few studies investigating the effect of non-ionizing radiation like
ultraviolet C light [63, 65]. It is further shown that even though p21 mRNA is expressed in
hESCs, functional p21 protein is not translated upon IR, presumably leading to a nonfunctional
G1/S checkpoint [79]. Consequently, hESCs revealing DNA damage can easily progress into S
phase, where the damage is amplified due to DNA replication, which might lead to apoptosis.
This could be part of a suicide strategy, by which cells with DNA damage might undergo apop-
tosis more efficiently instead of risking any misrepair that might be propagated to the daughter
cells [69].
hESCs also show special DNA repair characteristics compared to differentiated somatic cells
(reviewed in [62]). On the one hand, they are more sensitive to DNA damage, but on the other
hand they repair DNA damage with faster kinetics and more accurately [81]. This might at first
seem counter intuitive, however this strategy enables hESCs to exclude damaged cells from the
population by facilitated apoptosis and to maintain their genomic integrity efficiently. Going
more into detail, hESCs exhibit an elevated level of proteins involved in DNA repair [82]. While
differentiated somatic cells rely mainly on NHEJ as a DNA repair mechanism, hESCs exhibit
an ATM dependent HR as their preferentially used repair pathway. Additionally, it was found
that they also rely on NHEJ. However, this pathway might not necessarily resemble the classical
error-prone NHEJ used by differentiated somatic cells. Instead, Adams and colleagues found
that the NHEJ mechanism used in hESCs is independent of the typical cNHEJ protein DNA-PK,
as well as of PARP and ATM, and that it shows high fidelity instead of error prone characteristics
[83]. Another study by Bogomazova and colleagues revealed DNA-PK dependent NHEJ acting
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in late G2 phase, leading to chromatid exchanges [84]. The different results of these studies
show that there is still a need to elucidate the characteristic DDR of hESCs.
Massive cell death has been observed in hESC cultures using H9 cells exposed to sparsely IR.
Based on Annexin-V assay, Wilson and colleagues found a dose-dependent decrease of viable
cells 48 h after exposure to γ-rays, with a control level of 73% viable cells that drops to 32%
after only 0.4Gy, reaching a plateau of 5% viable cells after 2 and 4Gy, respectively. The
exposure to 2 and 4Gy resulted in holes and patchy regions in hESC colonies [80]. This patchy
morphology of exposed hESC colonies has also been observed by Momcilovic and colleagues,
who reported an increase in cleaved Caspase-3 positive cells at 4 h after 2Gy of γ-radiation [78].
Sokolov and colleagues reported no effect for 0.2Gy up to 65 h after γ-radiation. However, when
they increased the dose to 1Gy, viability dropped to 72% at 65 h after exposure (compared to
86-94% in controls) [85]. A study by Zou and colleagues report a loss of 99% of living cells
after 10Gy X-rays already after 5-7 h [86]. However, drawing a common conclusion from these
studies is difficult due to the different experimental approaches.
Studies on the effect of sparsely IR on alterations in gene expressions were mainly performed
by the groups of Wilson [80] and Sokolov [77]. Wilson and colleagues used microarray analy-
ses to investigate transcript levels of hESCs (H9) 48 h after 0.4, 2 and 4Gy of γ-radiation. They
report that VDR/retinoid X response (RXR) activation, p53 signaling, and aryl hydrocarbon
signaling pathways as well as cancer, cell death, cell cycle, growth and proliferation, and em-
bryonic development functions are mainly affected. They also observed a coclustering of gene
expression patterns in the sham irradiated samples and in the samples exposed to 0.4Gy, as well
as a coclustering of the samples exposed to 2 and 4Gy. Expression of pluripotency markers was
not significantly different compared to unexposed samples. Sokolov and colleagues also used
microarrays to investigate gene expression in exposed hESCs (H9). However they used a dose
of 1Gy γ-rays and analyzed the samples at earlier time points, namely 2 h and 16h post irradia-
tion. Just 2 h after exposure, they found only 30 genes that were upregulated, mainly involving
p53 related and pro-apoptotic genes. 16 h after irradiation, they found 354 upregulated genes
that were involved in pro-survival pathways. Their results concerning no differential expression
of pluripotency markers after IR exposure is in accordance with the study by Wilson [85, 87].
However, Sokolov also found that there can be large variations in gene expression among dif-
ferent hESC lines [88]. This variability of IR response among hESC lines has to be kept in mind
when interpreting results obtained with only one hESC line.
Non-targeted effects also known as bystander effects of IR have not been observed in hESCs
[89]. After transferring conditioned medium from hESCs exposed to 10Gy X-rays on unexposed
hESCs, Sokolov and colleagues neither observed an increase in apoptotic cells nor a significant
increase of radiation induced foci.
1.6 Early embryogenesis and in vitro differentiation towards definitive endoderm
hESCs are the closest in vitro model available for the early human embryogensis. In this work,
hESCs themselves (resembling cells from the epiblast) as well as their development into defini-
tive endoderm are investigated with respect to the influence of IR. An overview of the embryonic
development described in this section is given in [90] (see also figure 1.6A). In vivo, the embry-
onic development starts with the fertilized egg, the totipotent zygote. While it migrates down
the oviduct, it undergoes its first cell divisions called cleavages, during which the embryo does
not increase in size. Unlike other species, these initial cell divisions occur asynchronously (rota-
tional holoblastic) every 12 to 24 h and the embryo is independent of the maternal genome very
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quickly (at the two cell stage in mice). After three to four days, the human conceptus reaches the
16-cell stadium and is now called morula. The morula undergoes a process called compaction,
that prepares the embryo for the next developmental stage. During compaction, the cells form
gap junctions and tight junctions that bind the former loose cell aggregate together to a more
compact and tight array. The cells now start to secrete fluid inside the morula, creating a cavity
that ensures proper nutrition of cells positioned inside the growing embryo, namely the ICM.
The outer cell layer surrounding the blastocoel and the ICM is called the trophoblast. It will
give rise to extraembryonic tissues like the chorion thus providing the fetal part of the placenta.
At this stage, around five days after conception, the embryo is called a blastocyst. When arrived
at the uterus, the embryo hatches from the zona pellucida, the membrane that prevented its
implantation while migrating down the oviduct. It can now connect with the endometrium and
implant in the uterus around day seven to day eight. While the blastocyst buries itself deeper
into the endometrium, the ICM develops into a bilaminar embryo consisting of an upper cell
layer, the epiblast, and a lower cell layer, the hypoblast also known as primitive endoderm. The
cells of the latter are going to line the blastocoel below the hypoblast and form the inner lining
of the yolk sac. Above the epiblast, the amnionic cavity develops. The epiblast itself will give
rise to the actual organism. As a next hallmark of early embryogenesis, the gastrulation starts,
characterized by massive cell migration and resulting in the formation of the three germ layers
(definitive) endoderm, mesoderm and ectoderm. Between 14 and 16 days post conception, a
structure forms at the posterior end of the epiblast called the primitive node and the primitive
streak. Cells of the epiblast lose cell-cell contacts due to E-cadherin repression, undergo epithe-
lial to mesenchymal transition (EMT), migrate anterior together with the expanding primitive
streak and invade through the streak (also known as invagination). These cells displace the
hypoblast and form the definitive endoderm (DE) that will give rise to the epithelial lining of
the primitive gut tube that is the origin of the gastrointestinal tract, liver, pancreas and other
associated visceral organs. Before going more into detail concerning the development of endo-
derm (overview in [91]), the classification of the various terms of endoderm will be explained.
Besides the endoderm of the actual organism namely the DE, several extraembryonic endoder-
mal tissues exist. The hypoblast is equivalent to the primitive endoderm, the lower part of the
bilayered embryo in the blastocyst. A proportion of the cells of the primitive endoderm differ-
entiates into visceral endoderm, while another proportion undergoes EMT and differentiates
into parietal endoderm. This work concentrates more on DE than on extraembryonic endoderm
and I will therefore now focus on the DE. For further understanding of the endodermal devel-
opment, we have to rely on studies that were performed mainly in the frog (Xenopus laevis),
the chicken (Gallus gallus) and the mouse (Mus musculus). Even though many crucial steps in
endoderm development are evolutionary conserved, one has to be careful when extrapolating
the knowledge from one species to another. When migrating through the primitive streak, endo-
derm progenitors are exposed to temporally and spatially varying levels of signaling molecules
from the adjacent tissue. These varying signals allow the endoderm progenitors to differentiate
in a certain pattern aligned to the anterior posterior axis. The signals are mainly originating
from two areas, the primitive node and the anterior visceral endoderm. In between the epiblast
and endoderm stage, there is an intermediate cell type that expresses markers for both endo-
and mesoderm. These cells are called mesendoderm and are located in the anterior primitive
streak. The development of DE is mainly controlled by TGFβ signaling and canonical WNT
signaling (see figure 1.6B), as well as by other factors like SOX17 etc. NODAL (a member from
the TGFβ signaling pathway) expressed in the node is a crucial player in the DE development.
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When translated as a protein precursor ProNodal, it can be cleaved and activated by Furin and
PACE4, both secreted from the trophectoderm. NODAL can now act via different ways. It can
stimulate WNT signaling in the anterior primitive streak via BMP4 signaling. WNT signaling
acts on the promoter PEE, which promotes NODAL expression, therefore forming a positive
feedback loop. Furthermore, NODAL can stimulate its own expression via the promoter ASE.
Additionally, NODAL can stimulate the expression of Lefty2, which eventually inihibits NODAL,
therefore forming a negative feedback loop. Eomesodermin expressed in the trophectoderm is
also discussed to participate in a feedback loop of NODAL. The expression of NODAL in the
node eventually creates a protein gradient that leads in case of high levels to endoderm forma-
tion and in case of lower levels to mesoderm formation. Besides NODAL, GDF1 and GDF3 are
also expressed in the node. They can interact with NODAL and increase its activity in a way
that enables long-range signaling of NODAL [92]. Not only NODAL, but also the expression
of SOX17 seems to be dependent on canonical WNT signaling [93], and SOX17 itself plays an
important role in DE development. It has been shown in mice that SOX17-null mutant embryos
are deficient in developing a DE lining of the embryonic gut [94]. The authors conclude that
SOX17 is important for the maintenance of endoderm as well as for further endodermal cell fate
decisions. However, the mechanism governed by SOX17 is not yet revealed.
Despite this complex signaling network, it is possible to recapitulate the DE development in
vitro. D’Amour and colleagues developed a protocol that leads to an efficient differentiation
of hESCs into cells of the DE [40] (see also section 2.4). First of all, the pluripotent culture
needs to be depleted of conditions that would maintain their pluripotency and prevent differ-
entiation. Therefore, hESCs are adapted to feeder-free conditions on matrigel. Then, hESCs are
cultured for 24 h in medium containing WNT3A and Activin A. As Activin A acts as a surrogate
for NODAL, this conditions mimic the situation described in figure 1.6B. After these first 24 h,
cells are incubated in medium including serum and Activin A. The serum inhibits PI3K signaling,
which would otherwise prevent efficient DE differentiation [95]. Cells of the DE can already be
observed three days after initiation of differentiation.
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Figure 1.6: A: Early embryogenesis showing the fertilization of the zygote, the migration of the embryo down
the oviduct, undergoing cleavages that lead to the morula and after compaction to the blasytocyst. After hatching
from the zona pellucida, the blastocyst consisting of trophoblast (outer cell layer, yellow), epiblast (orange) and
hypoblast (green) implants into the endometrium of the uterus. From [96]. B: Signaling network resulting in
the development of DE. NODAL is regulated via positive and negative feedback loops including signals from cells
of the trophectoderm and the anterior primitive streak. Cells migrating through the streak that are exposed to
high concentrations and/or long exposure time of NODAL develop into endoderm, whereas exposure to lower
concentrations and/or shorter duration leads to mesoderm development. From [91].
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1.7 Motivation and objective
A need to further understand the effects of IR on the human embryonic development exists.
As a model system, hESCs can be exploited to elucidate the mechanisms behind the effects
of IR on the early human embryonic development, since they have the potential to recapitulate
these early developmental processes in vitro [28]. As discussed in section 1.5.3, hESCs comprise
unique properties to protect their genome in order to give rise to an intact and fully developed
organism. Based on studies of Stambrook, Dumitru, Nagaria and colleagues [69, 73, 62], we
hypothesize that hESCs exposed to IR exclude cells with induced DNA damage from the popu-
lation either by facilitated apoptosis, or high fidelity DSB repair that leads to a low frequency
of chromosome aberrations. As a consequence of these unique properties, hESCs surviving IR
exposure should be able to maintain their pluripotency. This hypothesis is supported by our
previous studies that revealed that mouse ESCs surviving the exposure to X-rays or C ions may
carry chromosomal aberrations, however, they are still able to maintain pluripotency [97]. To
test our hypothesis, hESCs were exposed to different radiation qualities in order to investigate
their IR induced DNA damage response. The hESC line H9 was used to overcome species spe-
cific differences between mouse and human cells. Furthermore, H9 cells are frequently used in
radiation investigating studies and this cell line is well characterized. Besides X-rays, the effect
of high LET radiation like accelerated C, Ca, Ni and Ti ions was investigated. Since the physical
interactions of these two radiation qualities with a target differ from each other (see 1.2), and
only few studies on the effect of low LET radiation on early mammalian embryonic development
were performed [98], it is of special interest to include high LET radiation in the investigations
of this study. For this, it was taken advantage of the particular heavy ion accelerator facility
available at GSI, Darmstadt. Doses of 1 to 3Gy were applied. Since this is the first study at
GSI investigating the radioresponse of hESCs, the labor-intensive cell culture itself as well as all
methods had first to be established. In characterizing studies, the size of the cell nucleus and
the cell cycle duration were measured. Various endpoints up to 14 days after exposure were
analyzed. The cell cycle progression with a focus on cell cycle blocks was observed up to 7 days,
and apoptosis based on cleaved Caspase-3 was observed in the first 48 h after exposure. Chro-
mosome aberrations after mFISH were scored in surviving progeny up to 14 days after exposure.
Alterations in cell potency based on pluripotency markers like OCT4 and SOX2 and underlying
embryonic signaling pathways were analyzed over 48 h. Additionally, the differentiation poten-
tial into one of the three germ layers, DE, was investigated until day 11 after exposure, based
on gene expression studies of the marker pair SOX17/SDF1.
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2 Material and methods
2.1 Cell culture
hESCs being investigated in this work were co-cultured with mouse embryonic fibroblast (MEF)
feeder cells. For the weekly passage, hESCs were either transferred enzymatically or manually
into the new culture vessels. The medium composition changed depending on the passaging
technique (H9-medium for enzymatic passage, see appendix table 4.2, and H9-medium for
manual passage, see appendix table 4.3). Cells were incubated at 37◦C with ambient oxygen
and 5% CO2. For medium compositions, refer to appendix.
2.1.1 Human embryonic stem cells
Cells of the hESC line WA09 (H9) were obtained from WiCell Research Institute, Wisconsin,
in passage number 26 and stored in liquid nitrogen. The import of hESCs (H9) as well as the
utilization of the cells in this study was approved on June 21, 2011 and appended on August 8,
2013 by the Robert-Koch-Institute (approval entry number 65) in concordance with the German
stem cell law (§11 StZG, [31]).
Thawing was performed according to WiCell protocols. Frozen hESCs were briefly thawed
in a 37◦C waterbath. Cell suspension was transferred into 9ml H9-medium and centrifuged
for 3min at 200 g for washing. The cell pellet was carefully resuspended with MEF-conditioned
medium not to break up the cell clumps into a single cell suspension. Cell clumps were plated on
a preseeded MEF feeder layer in a 6-well plate, with a total of 2.5ml MEF-conditioned medium
(preparation see table2.1.3).
hESCs (H9) were passaged every six to eight days based on appearance, i.e. cell density (since
overgrowing colonies start to differentiate) and morphology indicating spontaneous differenti-
ation. For enzymatic passaging, cells were cultured in T25 culture flasks. Hence, medium
was aspirated, 1ml dispase (6U/ml) was added and cells were incubated for 3 – 7min at
37 ◦C. Detached colonies were resuspended and centrifuged for 3.5min at 200 g. The pellet
was resuspended and splitted 1:3 – 1:5 on either matrigel coated T25 culture flasks in MEF-
conditioned medium or on a MEF feeder layer in new T25 culture flasks with H9-medium in-
cluding 10 ng/ml FGF2.
For manual passaging, cells were grown in petri dishes (21.5 cm2). Colonies to be passaged were
chosen due to morphologic characteristics, microdissected with a scalpel under a microscope
with a 100x magnification under an open laminar flow cabinet. Then, 15 dissected colonies were
transferred into a new petri dish with either MEF feeder and >1h pre-conditioned H9-medium
including 10ng/ml FGF2, or with a matrigel coated surface in MEF-conditioned medium (see
section 2.1.3). The manual passaging is depicted in figure 2.1.
For the feeder-free culture on a matrigel coated surface, matrigel was thawed on ice and
diluted 1:25 in cold KO-DMEM. Then, 7µl/cm2 diluted matrigel was used to coat the surface of
the culture vessel. The coated culture vessels were incubated for at least 1 h at 37◦C. Prior to
use, surplus liquid was aspirated and replaced with culture medium.
A medium change was performed every 24 h with H9-medium including 10ng/ml FGF2.
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Figure 2.1: Weekly manual passaging cycle. Colonies with pluripotency indicating morphology (lower left colony
in picture before step 1) are chosen, while colonies with differentiation indicating morphology (upper right colony
in picture before step 1) are excluded from the passage. This selection is not possible with enzymatic passaging.
Colonies are cut into squares (1) and transferred into a new culture vessel (2). The cell clumps attach and start to
grow (4, at two days after passage). When the colonies reach a certain size and density in the culture vessel, a
further manual passage is performed (5).
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2.1.2 Mouse embryonic fibroblasts
As a feeder layer for the hESCs (H9), cells of the mouse embryonic fibroblasts line PMEF-NL
were obtained from Millipore, Germany, in passage number three and stored in liquid nitrogen.
MEFs were expanded on gelatinized T75 culture flaks. Therefore, the cell growth surface of T75
culture flasks was coated with 0.1% gelatine in PBS-/- and incubated for at least 1 h. Then, the
gelatine was aspirated and the culture flasks were prefilled with MEF-medium.
MEFs were thawed and transferred in 9ml MEF-medium for washing. The cell suspension was
centrifuged for 5min at 200 g. The pellet was resuspended in MEF-medium and 1.5 to 2Mio
cells were plated in gelatinized T75 culture flasks in a total of 15ml MEF-medium.
Cells were passaged at 85 to 95% confluency and expanded up to passage 6. Therefore, ad-
herend MEFs were washed with 5ml PBS-/-, and incubated in 2ml trypsin (0.05% trypsin/
0.1% EDTA in PBS-/- for 5min at 37◦C. Detached MEFs were flushed off the culture surface
with MEF-medium and collected in 50ml reaction tubes. The cell suspension was centrifuged
for 5min at 200 g. The pellet was resuspended in MEF-medium and 1.5 to 2Mio cells were
plated on gelatinized T75 culture flasks in a total of 15ml MEF-medium.
In passage 6 at a confluency of 85 to 95%, cells were enzymatically harvested as described be-
fore, collected on ice and mitotically inactivated by exposing the cells in suspension to 2 x 30Gy
X-rays. Inactivated cells were centrifuged for 5min at 200 g and the pellet was resuspended in
1.8ml freezing-medium per 3Mio or 6Mio cells. The cells were frozen at -80◦C for 24 h and
then stored in liquid nitrogen.
To plate the feeder layer for hESCs, inactivated MEFs were thawed >12h prior to hESC pas-
saging. MEFs were washed as described before and plated on gelatinized culture vessels in
MEF-medium with a density of 33000MEFs/cm2.
2.1.3 Preparation of MEF-conditioned medium
To grow hESCs (H9) in feeder free conditions, cells were cultured in MEF-conditioned medium
on matrigel coated surfaces. Therefore, H9-medium containing 10 ng/ml FGF2 was incubated
24 h on 47000MEF/cm2. Every 24 h, the medium was exchanged and MEF-conditioned medium
was collected for four days. Prior to use, the MEF-conditioned medium was filtered through a
0.22µm pore size filter and 4ng/ml FGF2 were added.
2.2 Irradiation procedures
2.2.1 X-ray irradiation
For X-ray exposure, an Isovolt DS1 X-ray tube (Seifert, Ahrensberg, Germany) with settings of
250 kV voltage and 16mA current was used. The X-ray tube is equipped with a filter system
consisting of 7mm Be, 1mm Al and 1mm Cu to absorb soft X-rays. The dose was measured
with an SN4-dosimeter (PTW, Freiburg, Germany). Cells were exposed at RT, with dose rates
of approximately 2Gy/min. In case of hESC exposure, the duration of the total irradiation
procedure including exposure and transport between the incubator and the X-ray tube was on
average 30min. For the inactivation of MEFs, the average duration of the procedure including
cell harvest, exposure, transport and resuspension in freezing-medium was approximately 1 to
4 h. The positioning of the sample for X-ray irradiation is shown in figure 2.2.
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Figure 2.2: X-ray irradiation. The
sample is positioned horizontally
below the exit window of the X-ray
tube. The sensor of the dosimeter
is placed as close as possible to the
cells.
2.2.2 Ion irradiation
Irradiation of cells with heavy ions was performed at the heavy ion synchrotron SIS18 at GSI,
Darmstadt. For 25mm Spread Out Bragg Peak (SOBP) irradiation, the beam is first passing
a 60mm polyethylenbolus in order to adjust its energy. The pencil beam moves continuously
over the target by using the raster scanning technique to ensure a defined number of particles
being delivered at a certain raster point [99]. Ion species, their energies and corresponding
characteristics are summarized in table 2.1. For exposure to heavy ions, cells were seeded in T25
culture flasks, that were filled up with H9-medium not containing knockout serum replacement
prior to exposure. The flasks were positioned vertically and the surface with the adherent
cells perpendicular to the beam exit window on a remotely controlled conveyor belt (see figure
2.3). Cells were exposed at RT. Mean duration of the total ion irradiation procedure including
transport between the incubator and the synchrotron irradiation room was 45min.
Table 2.1: Ion species, energy, LET on target and dose applied during irradiations with heavy ions
Ion species Energy LET on target Dose
Carbon 106 - 147 MeV/u (SOBP) 75 keV/µm (dose averaged) 1 Gy
Calcium 1 GeV/u 89 keV/µm 1 Gy
Titanium 1 GeV/u 107 keV/µm 3 Gy
Nickel 1 GeV/u 174 keV/µm 1 Gy
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Figure 2.3: Ion irradiation. Upper
picture: Beam line coming from the
left, pointing at the vertically posi-
tioned culture vessels on the con-
veyor belt. Lower picture: Adher-
ent hESCs (H9) in T25 culture flasks,
filled up with medium. The cell
growth surface is pointing into the
direction of the beam.
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2.3 Determination of the nuclear size and the number of particle traversals per nucleus
Knowing the cross-section of a hESC nucleus (Acel l nucleus) as well as the particle fluence (F), the
number of particle traversals per cell nucleus can be determined.
Therefore, adherent hESCs (H9) growing on cover slips were washed with PBS+/+ and incu-
bated in 3.7% PFA for 20min at room temperature (RT) for fixation. After three washing steps
with PBS-/-, cells were stained with 5µg/ml Hoechst 33 342. Measurement of stained cell nuclei
was performed in Nikon NIS elements software by automatic object recognition.
The fluence, describing the number of particle traversal per unit area, can be calculated ac-
cording to the following equation, where D is the dose in Gy, LET is the linear energy transfer in
keV/µm, F is the particle fluence in cm-2 and ρ is the density of the target (1 cm3/g for water):
D = 1.602 · 10−9 · LET · F ·
1
ρ
(2.1)
The number of particle traversals per cell nucleus is then calculated according to:
F · Acel l nucleus = N par t icle t rav ersals
cel l nucleus
(2.2)
2.4 Differentiation into definitive endoderm
hESCs were differentiated into DE based on a protocol from D’Amour and colleagues [40].
For this, hESCs (H9) were cultured in petri dishes on MEF under pluripotency maintaining
culture conditions. Four days after the manual passage, cells were irradiated with 1Gy X-rays
or sham irradiated. Then, cells coming from two petri dishes were pooled and transferred to
one matrigel-coated petri dish containing MEF-conditioned medium (day -2). After 48 h (day
0), cells were washed with PBS+/+ and cultured in 3ml DE-medium including 25 ng/ml Wnt3a.
From day 1 to day 7, medium was exchanged daily with new DE-medium including 0.2% FCS.
A time line of this experimental procedure is shown in figure 2.4.
Figure 2.4: Time line of the experimental procedure for differentiation towards DE, including irradiation and
directed differentiation of the cells from day -8 to day 7.
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2.5 Proliferation assay
For analysis of cell cycle duration, the Click-iT® EdU Alexa Fluor® 488 Flow Cytometry Assay Kit
(Invitrogen) was used. Manually passaged hESCs (H9) (passage 25) grown on MEF feeder cells
in petri dishes were pulse labeled with 10µM EdU in H9-medium for 50min. Then, cells were
washed and incubated in H9-medium and/or harvested at various timepoints (0, 12, 16, 20 and
24h). For the fixation, permeabilisation and staining procedure, the manufacturers protocol was
followed. Additionally, cells were stained with 1µg/ml DAPI. Cells were subsequently analyzed
by flow cytometry.
2.6 Apoptosis assay and simultaneous cell cycle analysis
Apoptotic cells were identified due to immunochemical staining of activated caspase-3. hESCs
(H9) were cultured on matrigel to deplete MEF cells. A medium exchange was performed prior
to exposure to exclude apoptotic cells not caused by irradiation. Due to the high metabolic activ-
ity of hESCs, a further medium change had to be performed after 24 h. Cells were incubated for
20min in 1% EDTA in PBS-/- to obtain a single cell suspension. For staining of active caspase-3,
the FITC Active Caspase-3 Apoptosis Kit (BD) was used according to the manufacturers proto-
col. Stained cells were additionally incubated in 1µg/ml DAPI to allow simultaneous cell cycle
analysis. Processed samples were measured by flow cytometry. For time points >24h, the sec-
ond medium change has to be taken into account in the data analysis of apoptosis induction.
Therefore, the actual fraction of apoptotic cells at more than 24h (A(>24h+mc)) was calculated
according to equation 2.5 that was derived as follows:
S(>24h+mc) = S(24h) · S(>24h−mc) (2.3)
1− A(>24h+mc) = (1− A(24h)) · (1− A(>24h−mc)) (2.4)
A(>24h+mc) = 1− (1− A(24h)) · (1− A(>24h−mc)) (2.5)
where S(24h) is the fraction of surviving cells observed at 24 h, S(>24h−mc) is the fraction of sur-
viving cells observed at a time point later than 24h without taking into account the medium
change, and A is the fraction of apoptotic cells, respectively.
2.7 Cytogenetic analysis
To accumulate cells in metaphase, hESCs (H9) were incubated in H9-medium including
10µg/ml colcemid for 3 h at 37◦C. Then, cells were washed with PBS-/- and enzymatically
detached with trypsin to obtain a single cell suspension. The enzyme reaction was stopped
by adding 3ml MEF medium and the cell suspension was transferred into a 15ml reaction tube
and centrifuged for 6min at 200 g and RT. For hypotonic treatment, cells were resuspended care-
fully in 8ml 37◦C prewarmed KCl solution (0.075M in H2O) and incubated for 7min at 37
◦C.
Afterwards, 1.5ml fixative (methanol:acetic acid 3:1) were added and cells were centrifuged
for 10min at 200 g and RT. The cell pellet was resuspended in 10ml fixative, centrifuged and
resuspended in ∼1ml fixative. Cells were either stored at 4◦C or subsequently dropped onto
microscope slides.
Air dried metaphase spreads were hybridized with the 24xCyte Human Multicolor FISH
Probe Kit (Metasystems) according to the manufacturers protocol and images of the metaphase
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spreads were captured with an Axio Imager Z1 microscope (Zeiss) and Metafer software, and
analyzed with ISIS software.
Structural chromosomal aberrations were scored and subdivided in the following categories,
based on the classification of M. N. Cornforth [100, 14] (see also figure 1.3 for an illustration
of various structural aberrations). Breaks comprise chromosomal aberrations such as truncated
chromosomes with and without related acentric fragment as well as lonely acentric fragments.
They result due to a terminal deletion after one break or due to an interstitial deletion due
to 2 breaks in a chromosome. Simple exchanges consist of the subcategories reciprocal and
non-reciprocal exchanges as well as dicentrics. Reciprocal translocations result due to a sym-
metric reciprocal interchange of two broken chromosomes. Non-reciprocal translocations are
also known as one-way exchanges. They either represent true incomplete exchanges resulting
due to an incomplete symmetric reciprocal interchange of two broken chromosomes, or they
represent terminal translocations characterized by a small fragment near the telomeres of a
chromosome which exceeds the resolution of the mFISH technique. Dicentric chromosomes
(with and without related acentric fragment)result due to an asymmetric reciprocal interchange
of two broken chromosomes. Complex aberrations result after ≥3 breaks in ≥2 chromosomes.
The complexity of complex aberrations was quantified by means of the CAB system [101, 14].
This system is recording the number of chromosomes (C), the number of arms (A), and the
number of breaks (B) involved in a certain complex aberration. Cells with the same aberrations,
i.e. clones, were scored as only one aberrant cell.
2.8 Individual mRNA expression analysis based on quantitative RT-PCR using the
standard curve method
For cell lysation, samples were washed with PBS+/+ and lysed by adding 700µl QIAzol lysis
reagent according to the protocol of the miRNeasy Mini Kit (Qiagen). Cells were scraped of the
culture vessel and the suspension was collected in a 2ml reaction tube. After 5min incubation
at RT, cell lysates were stored at -80◦C.
Simultaneous isolation of miRNA and total RNA was performed according to the miRNeasy
Mini Kit protocol, using chloroform to separate RNA from DNA and proteins, and spin columns
to enrich miRNA and total RNA. RNA concentration and purity were analyzed using the Col-
ibri microvolume spectrophotometer (Titertek Berthold). If not processed immediately, isolated
RNA was stored at -80◦C.
In case of an RNA concentration below 1µg/ml or bad quality of RNA absorbance spectra indi-
cating contamination (significantly lower ratio of the absorbance at 260 nm and 280nm), RNA
was purified by adding 1/10 volume of cold 3M sodium acetate and 1 volume of cold iso-
propanol. After an incubation of 3 h at -20◦C, the sample was centrifuged at 20000 g for 15min.
The pellet was rinsed in 30µl 70% ethanol and centrifuged again at 21000 g for 2min. The air
dryed pellet was resuspended in 10µl nuclease free water.
For the conversion of total RNA to cDNA, the RevertAid RT Kit (Thermo Fisher Scientific) with
its provided protocol was used. Incubation steps were performed in a thermocycler. If not fur-
ther processed, cDNA samples were stored at -20◦C.
For quantitative rtPCR, 2µl cDNA was mixed with 4µl 5x HOT FIREPol® EvaGreen® qPCR Mix
Plus (ROX), 1µl forward and 1µl reverse primer and 12µl nuclease free water. For each sample,
triplicates were pipetted into a 96 well plate. The plate was sealed, centrifuged and placed into
the qRT-PCR instrument (StepOnePlus™Real-Time PCR System, ABI) with the following cycle
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settings: 15min at 95◦C, one cycle, for initial denaturation and polymerase activation, 15 sec at
95◦C followed by 1min at 60◦C, 40 cycles for denaturation, annealing and elongation. A melt
curve analysis was appended to these settings.
Data analysis was performed with ABI StepOne Software v2.3, applying the relative standard
curve method to relate obtained sample CT values to known concentrations of human fetal
liver tissue total RNA or RNA samples from pluripotent hESCs (H9). Primers are listed in the
appendix, see table 4.8.
2.9 Stem cell signaling mRNA array analysis
For cell lysation, enzymatically harvested cells were centrifuged and the cell pellet was processed
according to the manufacturers protocol of the MasterPure™RNA Purification Kit (Epicentre).
If not processed immediately, lysates were stored at -80◦C. RNA concentration and purity were
analyzed with the Colibri microvolume spectrophotometer. Using the RT 2 First Strand Kit (Qi-
agen), RNA was converted into cDNA according to the manufacturers protocol. cDNA and RT 2
qPCR Master Mixes (Qiagen) diluted with nuclease free water was pipetted according to the
manufacturers protocol into the Human Stem Cell Signaling PCR Array (Qiagen) already in-
cluding primer sets of 5 housekeeping genes as well as 84 genes of interest. The plate was
sealed, centrifuged and placed into the qRT-PCR instrument with the following cycle settings:
10min at 95◦C, one cycle, for initial denaturation and polymerase activation, 15 sec at 95◦C
followed by 1min at 60◦C, 40 cycles for denaturation, annealing and elongation. A melt curve
analysis was appended to these settings. Data analysis was performed with StepOne Software
v2.3 (Applied Biosystems), applying the comparative CT method (delta delta CT). Primer sets
for genes already included in the array are listed in the appendix, table 4.9.
2.10 Immunocytochemical analyses of pluripotency and differentiation markers
For fluorescence microscopy analysis of pluripotency markers, hESCs (H9) were grown and
stained on cover slips. Cells were washed with PBS+/+ and incubated in 3.7% PFA for 20min
at RT for fixation. After three washing steps with PBS-/-, cells were permeabilized with 1% FCS
+ 0.1% Triton-X in PBS-/- for 30min at RT for intracellular staining, and blocked with 3.5% FCS
in PBS-/- for >30min at RT. Then, cells were incubated in primary or directly labelled antibody
dilution for 45min at 37◦C, washed 3 times in PBS-/- and, in case of not directly labelled anti-
bodies, incubated in secondary antibody dilution for 30min at 37◦C. After three further washing
steps in PBS-/-, cells were stained with 5µg/ml Hoechst 33 342. Table 2.2 summarizes applied
antibodies and concentrations or dilutions.
For flow cytometric analysis of pluripotency state of hESCs, cells were incubated for 20min in
1% EDTA in PBS-/-, resuspended and passed trough a 40µm cell strainer to obtain a single cell
suspension. Cell concentration was dertermined and cells were washed and centrifuged at 300 g
for 5min. The cell pellet was resuspended in PBS-/- and the BD Stemflow™Human and Mouse
Table 2.2: Antibodies applied for immunocytochemistry
antibody concentration or dilution
anti-Oct3/4 (C-10) 1:100
goat anti-mouse Alexa Fluor® 488 1:400
anti-human Nanog Alexa Fluor® 488 2,5µg/ml
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Pluripotent Stem Cell Analysis Kit (BD) was used according to the manufacturers protocol. Cells
were stained for the differentiation marker SSEA1 and for the pluripotency marker SSEA4.
2.11 Flow cytometry
Stained cells were measured in BD FacsCanto II flow cytometer equipped with 3 lasers (405 nm,
488nm and 633nm) and 8 detectors (SSC488/10BP, FITC530/30BP, PE 585/42BP, PerCP-Cy5.5,
PerCp 670LP, PE-Cy7 780/60BP; APC660/20BP, APC-Cy7 780/60BP; AmCyan 510/50BP, Pacific
Blue 450/50BP) with the software BD FACSDiva™v7.0. For all measurements, the pulse signal
of a single event passing through the laser is recorded as integrated area, indicated in histograms
and dotplots as “A”. Data analysis was performed with the software FlowJo V.7.6.5 for cell cycle
analysis and V.10 for all other stainings.
2.12 Statistical analysis
In case of n>2 experiments, error bars represent the standard error of the mean. In case of n≤2
experiments, error bars were calculated according to Poisson statistics. Statistical significance
was calculated based on Fisher’s exact test for cytogenetic analysis and Student’s t-test for gene
expression analysis.
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3 Results
3.1 Average size of hESC (H9) cell nucleus and number of particle traversals per cell
nucleus
As described in section 2.3, the size of 32 adherent hESC (H9) cell nuclei in a microscopic field
was measured at day 5 after seeding. The mean area ± standard deviation is 198±52µm2.
Figure 3.1 shows an exemplary measurement of a cell nucleus.
The fluence calculated according to equation 2.1, and the number of particle traversals per
nucleus calculated according to equation 2.2 is shown in table 3.1. In all ion irradiation experi-
ments, each cell had an average of at least 12 hits per nucleus.
Table 3.1: Table describing the number of particle traversals per cell nucleus for the different ion irradiation
conditions. ∗dose averaged LET (SOBP).
Ion species Dose (Gy) LET (keV/µm) Fluence (cm-2) Traversals/nucleus
C 1 75∗ 8.3· 106 16
Ca 1 89 7.0· 106 14
Ni 1 107 5.8· 106 12
Ti 3 174 1.1· 107 21
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Figure 3.1: Measurement of the area of a hESC (H9) nucleus stained with Hoechst 33 342. Adherent cells were
growing on cover slips. 300 x magnification.
3.2 Qualitative verification of pluripotent cell cultures
The pluripotency of the initial hESC culture used for irradiation experiments was verified based
on immunocytochemistry. Figure 3.2 shows positively labeled cells and colonies of a man-
ually passaged culture for the core pluripotency markers NANOG and OCT4A, proving their
pluripotent state. Negatively labeled MEFs are indicated exemplarily with yellow arrows and
automatically serve as a negative control for the specificity of the antibodies. Interestingly, the
hESC colonies shown in 100-fold magnification exhibit less intense and more intense labeled
areas. Furthermore, mitotic cells indicated with white arrows reveal that the localization of
OCT4A is not anymore restricted to the nucleus, but is now distributed throughout the cy-
toplasm. In contrast, NANOG labeling seems much weaker in mitotic cells. Apoptotic cells
(morphologically identified based on characteristically condensed DNA) are indicated with red
arrows. Both pluripotency markers OCT4A and NANOG are not detectable in apoptotic cells.
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Figure 3.2: Immunocytochemical labeling of hESCs (H9) against pluripotency markers OCT4A (upper two rows)
and NANOG (lower two rows) both with Alexa Fluor®488 (green), counterstained with Hoechst 33 342 (blue).
White arrows exemplarily indicate mitotic cells, yellow arrows indicate MEFs, and red arrows indicate apoptotic
cells.
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3.3 Cell cycle duration
The cell cycle duration is a prerequisite for the experimental design of further endpoints like
chromosome aberrations and for the interpretation of further results. The EdU pulse labeling
assay provides a good estimate of the time the cells need to progress from one S phase to
another.
First, the protocol had to be optimized in terms of adapting the EdU incorporation during DNA
replication to the hESCs (H9). Therefore, three different combinations of EdU concentrations
and incubation durations were tested. These are: 5µM for 50min, 5µM for 2 h and 10µM
for 50min. The best discrimination between G1, S and G2 phase cells was achieved with the
protocol using 10µM EdU for 50min (see figure 3.3).
The determination of the cell cycle duration is shown in figure 3.4. While at 0 h only hESCs
(H9) in S phase (40%) are labeled, these cells have already progressed into G2 phase after 12 h,
and further progress through mitosis into G1 phase, visible at 16 h. Between 16 and 20h, most
of the initially labeled S phase cells entered S phase again, speaking for a cell cycle duration of
approximately 16-20 h.
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Figure 3.3: Cell suspension of
hESCs (H9) incubated in 10µM EdU
for 50min, immediately harvested
for analysis. Incorporated EdU is
immunocytochemically labeled with
Alexa Fluor®488 (green) and DNA
is stained with DAPI (blue). Cells in S
phase are shown in green and blue,
while cells in other cell cycle phases
like mitosis (indicated with white ar-
rows), or apoptotic cells (indicated
with red arrows) did not incorpo-
rate any EdU and are shown in blue.
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Figure 3.4: Determining the cell cycle duration of hESCs (H9). Flow cytometry measurement at 0, 12, 16, 20
and 24h after EdU pulse labeling and counterstaining with DAPI. For every time point the gating strategy with
corresponding frequencies of cells in its gated subgroup is shown together with its forward scatter versus side
scatter contour plot, followed by the DNA histogram and the EdU-Alexa488-A versus DAPI-A dotplot.
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3.4 Cell cycle progression
To determine the effect of IR on the cell cycle progression of hESCs (H9), cells were stained
with DAPI allowing a quantification of the DNA content via flow cytometry. The resulting DNA
histogram was analyzed with cell cycle fitting algorithms. The fraction of cells in G2/M phase
was measured in three experiments differing with respect to the initial cell culture methods
(enzymatically or manually passaged) and the radiation qualities. These three experiments are:
an enzymatically passaged culture exposed to 1Gy Ni ions, 1Gy X-rays, and related controls
(see figure 3.5A), a manually passaged culture exposed to 1Gy X-rays and related control (see
figure 3.5B), and an enzymatically passaged culture exposed to 1Gy Ca ions, 1Gy X-rays, and
related controls (see figure 3.5C).
All controls of the three experiments have a mean fraction of 36±3% of cells in G1 phase,
41±2% in S phase, and 19±1% of cells in G2/M phase (mean ± standard error of them mean).
Interestingly, just like most exposed samples, also the controls show an initially elevated level
of cells in G2/M phase compared to later time points after 24 h.
The main observations on the cell cycle progression in radiation exposed samples are now
described separately for each of the three experiments. In the experiment with Ni and X-ray
irradiation, both exposed samples show a clearly elevated fraction of cells in G2 phase at 7 h
compared to the sham treated control. After 7 h, the fraction of cells in G2/M phase of both irra-
diated samples approaches the levels of the sham treated control (figure 3.5A). The experiment
with manually passaged cells shows a lower fraction of X-ray irradiated cells compared to con-
trol after 24 h, while in the light of biological variability no conclusion regarding the statistical
significance can be drawn (figure 3.5B). The third experiment with cells exposed to Ca ions and
X-rays exhibits a similar G2/M phase progression in both incubator and sham treated control
cells. Exposed samples show a higher fraction of cells in G2/M phase at 7 and 24h compared
to both controls (figure 3.5C).
Sample pairs with biological triplicates (n=3) were tested for statistical significance (Student’s
t-test; p<0.005). At 24 h, the fraction of G2/M cells in Ca ion exposed samples is significantly
higher than the sham treated control, while the X-ray exposed sample is not significantly differ-
ent (figure 3.5C).
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Figure 3.5: Fraction of cells in G2/M phase. A1: Cell Cycle profiles corresponding to the data shown in A2 as
derived from flow cytometry. The fitting of the cell cycle is exemplarily indicated for the sham treated control
sample after 7 h. Cells in G1 phase are indicated in green; cells in S phase are indicated in grey; cells in G2/M phase
are indicated in blue; overall fit is indicated as red line. A2: Measurements of enzymatically passaged cultures
exposed to 1Gy Ni ions and X-rays. B: Measurements of manually passaged cultures exposed to 1Gy X-rays. C:
Measurements of enzymatically passaged cultures exposed to 1Gy Ca ions and X-rays. Error bars in B 24 h 1Gy
X-rays, and in C 24 h sham treated control, 1 Gy X-rays, 1Gy Ca ions represent standard error of the mean of three
biologically independent samples (n=3). All other error bars represent n=1 sample and are calculated according to
Poisson statistics. If absent, error bars are too small to be shown.
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3.5 Cell death
The apoptosis inducing effect of IR on hESCs (H9) was investigated by an immunocytochemical
staining of cleaved Caspase-3 followed by flow cytometric quantification.
A clear increase of detached cells was visible 24 h after exposure to 1Gy X-rays, as shown
in figure 3.6. While the sham treated control exhibits only few cells floating in the medium,
the exposed sample shows a strong increase of detached, probably apoptotic cells, that partially
obscure the colony below.
The results of three different experiments are shown in figure 3.7. These three experiments
represent enzymatically passaged cultures with either Ni ions and X-ray exposed samples (A),
enzymatically passaged cultures with Ca ions and X-ray exposed samples (B), and a manually
passaged culture exposed to X-rays (C).
The mean fraction of apoptotic cells of all controls from the enzymatically passaged culture
experiments A and B is 0.025±0.005 (mean±standard error). However, the manually passaged
control revealed an apoptotic fraction that was five times higher than the mean of all other
enzymatically passaged controls.
The slope of ion exposed samples always exceeds that of its corresponding X-ray exposed
counterpart, indicating that the fraction of apoptotic cells increases time and radiation quality
dependent. An inter-experimental variability is observed when comparing the three X-ray ex-
posed samples of experiments A, B and C at 24 h: While the lowest fraction of apoptotic cells is
found in experiment A, the fraction of apoptotic cells in experiment B increases by a factor of
two (and is higher than the Ni ion exposed sample of experiment A), and the fraction of apop-
totic cells in experiment C increases by a factor of five compared to that in experiment A (and is
higher than the Ca ion exposed sample of experiment B). The highest fraction of apoptotic cells
was observed at 48 h after an exposure to 1Gy Ca ions, that is 0.51.
Statistical significance was determined in case of n=3 biological triplicates (Student’s t-test;
p<0.05). The fractions of apoptotic cells at 24 h after exposure in sham treated control, 1Gy X-
rays, and 1Gy Ca ions (LET=89keV/µm) exposed samples in experiment B are all significantly
different to each other. Also, the fractions of apoptotic cells at 24 h after exposure to 1Gy X-rays
in enzymatically passaged cultures (B) and in manually passaged cultures (C) are significantly
different. All of those four samples are significantly different to each other with p<0.05.
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Figure 3.6: hESCs (H9) sham treated (A) and exposed to 1Gy X-rays (B) at 24 h after exposure. Light-microscopic
picture, 50x magnification. Floating cells, presumably apoptotic, appear as shiny spheres.
Figure 3.7: Fraction of apoptotic cells up to 50 h after exposure to heavy ion radiation or X-rays. Experiment A and
B represent two independent experiments based on enzymatically passaged hESC cultures. Experiment C depicts a
manually passaged culture. Error bars for the data points at 24 h of samples 1Gy X-rays B, 1Gy X-rays C and 1Gy
Ca ions B represent the standard error of the mean of n=3 biologically independent samples. Error bars of all other
data points are calculated according to Poisson statistics. If absent, error bars are too small to be shown.
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3.6 Pluripotency and differentiation marker expression in pluripotency maintaining
culture conditions
To investigate the pluripotency state of irradiated hESCs (H9) cultured under pluripotency main-
taining conditions, cells were stained for the pluripotency-associated surface marker SSEA4 and
the differentiation-specific surface marker SSEA1 and quantified via flow cytometry.
The results are shown in figure 3.8. In panel A, the fraction of cells positive for SSEA4 is
plotted 7 and 50h after irradiation. The mean fraction of SSEA4 positive hESCs (H9) in three
biologically independent control samples is 0.993 with a standard deviation of 0.008. In all irra-
diated samples, the fraction of SSEA4 positive cells is higher than 0.99 but within the standard
deviation of the control.
Panel B shows the fraction of cells positive for the differentiation marker SSEA1. The fraction
of SSEA1 positive cells in control samples is 0.087±0.013 (mean of n=3 biological independent
samples ± standard deviation). The exposed samples show a higher fraction of SSEA1 positive
cells than the control samples, increasing to a maximum of 0.163. To determine a statistical
significance that represents the biological variability, the sample size for exposed cells would
have had to be increased, which was not feasible during the current study.
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Figure 3.8: Flow cytometric quantification of pluripotency and differentiation markers in enzymatically passaged
cultures exposed to 1Gy X-rays and 1Gy Ni ions (LET=174 keV/µm). The control represents n=3 biologically indepen-
dent samples. Data points of 1Gy X-rays and 1Gy Ni ions represent n=1 sample with error bars calculated according
to Poisson statistics. A: Fraction of cells positive for pluripotency marker SSEA4. B: Fraction of cells positive for
differentiation marker SSEA1.
3.7 Chromosomal aberrations
Structural chromosomal aberrations were investigated via mFISH. Examples of karyogramms
for an undamaged hESC (H9) and a damaged cell are shown in figure 3.9. Figure 3.10 summa-
rizes the results from enzymatically and manually passaged samples, irradiated or sham treated,
at three different time points. The fraction of aberrant cells increases in a radiation quality de-
pendent manner. The lowest fraction of aberrant cells, i.e. 0 aberrant cells was only found in
manually passaged samples. These comprise sham treated controls at 4 days and at 14 days as
well as 1Gy X-ray exposed cells at 14 days. The fraction of aberrant cells is highest in samples
at 20 h and decreases with time. The categories of chromosomal aberrations reveal a broad
spectrum in exposed samples after 20 h. After 14 days, only transmissible translocations are de-
tected, except for a single truncated chromosome in the sample exposed to 1 Gy C ions. In cells
14 days after exposure to 1Gy C ions, two clones were observed, and each clone was scored as
one single event. One clone comprised three cells, characterized by a transmissible, reciprocal
translocation involving chromosomes 6 and 7 (also depicted in figure 3.9B). The second clone
comprised two cells, harboring a transmissible, reciprocal translocation involving chromosomes
1 and 19. Most non-transmissible aberrations, e.g. dicentrics, only appear in first mitotic cells
at 20 h and are not detected in the progeny at later time points. Complex aberrations were
only found in enzymatically passaged samples, and there is no significant difference between
the frequency of complex aberrations in heavy ion irradiated and X-ray exposed samples. The
complexity of all observed complex aberrations as described by the CAB number (number of
involved chromosomes (C), number of involved chromosome arms (A), and number of breaks
(B)) is as following:
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Sample Number of complex aberrations C/A/B transmissible (yes/no)
20 h 1 Gy X-rays (enz.) 3 4/4/4 no
2/2/3 no
5/5/5 no
20 h 1 Gy C ions (enz.) 1 3/4/4 no
4 d 1 Gy X-rays (enz.) 2 3/3/3 yes
3/3/3 yes
The distribution of the number of aberrations per cell is broader in samples exposed to densely
IR than it is in samples exposed to X-rays (data not shown). The frequency of a certain chromo-
some involved in aberrations is highest for chromosome 1 (involved in 11 of 53 scored aberra-
tions in a total of 1421 analyzed metaphases) and lowest for chromosomes 20 and 22 (involved
in none of all scored aberrations).
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Figure 3.9: Karyotypes examplarily showing hESC (H9) chromosomes after mFISH. A: Karyogram (A1) and corre-
sponding metaphase spread (A2) of a normal cell. B: Karyogram of a damaged cell at 14 days after exposure to 1Gy
X-rays (B1), exhibiting a reciprocal translocation between chromosomes 6 and 7 (indicated as t(6’-t) and t(7’-6)).
The chromosomes involved in the reciprocal translocation are magnified in B2.
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Figure 3.10: Cytogenetic analysis of hESCs (H9). A: Table illustrating the number of radiation induced aberrant
cells as well as a breakdown of aberration types observed. Uncertainties of the fraction of aberrant cells were cal-
culated according to Poisson statistics. Statistical significance (p<0.05) between two samples was calculated based
on Fisher’s exact test and is indicated by the same typographical symbol (†, ‡, §). Cells with the same aberrations,
i.e. clones, were scored as only one aberrant cell. Clones appeared only in one sample, i.e. in cells 14 days after
exposure to 1Gy C ions, indicated with ∗. B: Diagram showing the fraction of aberrant cells at 20 h, 4 d and 14d
after exposure. Data from manually and enzymatically passaged controls, as well as manually and enzymatically
passaged cultures exposed to 1Gy X-rays were pooled.
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3.8 Alterations in embryonic pathway signaling
To investigate alterations in stem cell signaling pathways due to IR, a qRT-PCR array already in-
cluding primer sets for the detection of 89 different mRNAs was applied. As a first overview, the
clustergrams of 21 enzymatically passaged samples as well as the clustergram of ten manually
passaged samples are shown in figure 3.11. Expression data are clustered two dimensionally as
groups of similar samples and groups of matching markers. For the samples of the enzymatically
passaged culture, no radiation-specific expression pattern can be recognized. In contrast, the
samples of the manually passaged culture cluster together in a related order, with two groups of
genes that show one common gene expression pattern in all six controls and another common
gene expression pattern in all four exposed samples. The pattern reveals 61 genes commonly
expressed with a high magnitude in control samples, and expressed with a low magnitude in
exposed samples. Another group consisting of 20 genes is expressed in a mostly low magni-
tude in the control samples and expressed in a mostly high magnitude in exposed samples. For
a more detailed analysis, dotplots were calculated for those samples belonging to a group of
three either biological or technical replicates (see figure 3.12). The significantly up or down-
regulated markers of the exposed sample group compared to their related sham treated control
group are listed in the corners of the dot plots. The exposed samples that represent biological
triplicates reveal more downregulated than upregulated genes compared to their related sham
treated control. The largest number of significantly downregulated genes compared to control
was found in the manually passaged culture 24 h after an exposure to 1Gy X-rays.
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Figure 3.11: Stem cell signaling array: clustergrams. A two dimensional clustering (i.e., relation of the 89 genes
and relation of the different samples) is shown for 21 different samples originating from enzymatically passaged
cultures on the left, and for 10 samples stemming from manually passaged cultures on the right. The minimum
magnitude of gene expression for a certain gene over all samples in one clustergram is indicated in green, while the
maximum magnitude of gene expression is indicated in red.
Figure 3.12: Stem cell signaling array: fold change gene expression analyses (2−∆∆C T ). Of all 21 enzymatically
passaged culture samples and all 10 manually passaged culture samples, only those belonging to a group of three
replicates (biological or technical) are displayed. A: Dotplots showing the fold change gene expression of exposed
versus sham treated control samples. Upper three dotplots show data from enzymatically passaged cultures ex-
posed to 3Gy X-rays or 3Gy Ti ions, harvested after 24 h or 7 d. The lower dotplot shows data from a manually
passaged culture exposed to 1Gy X-rays, harvested after 24 h. Significantly up or downregulated genes according
to Student’s t -test (p<0.05) are listed in the corners of the dotplots. B: Table showing the promoting or depressing
effect of all listed significantly up or down regulated genes, arranged in their corresponding pathway groups.
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3.9 Differentiation capability into definitive endoderm
The differentiation capability of hESCs (H9) surviving the exposure to IR was investigated by
inducing directed differentiation into DE four days after exposure (see section 2.4). The dif-
ferentiation efficiency was monitored by gene expression studies of the pluripotency markers
OCT4A and SOX2 and of the DE marker set SOX17high/ SDF1low. To date a single marker for DE
is not known, and SOX17 alone is also a marker for extraembryonic endoderm. Therefore, this
marker is used in combination with SDF1, which is a marker for extraembryonic endoderm but
absent in DE.
In figure 3.13, the different morphologies of exposed and unexposed hESCs (H9) before and
after differentiation are shown exemplarily. At day -2, hESCs (H9) appear in their typical stem
cell morphology: Cells are arranged in very compact colonies with a more loose structure at
the growing border. It should be noted that the colonies in the exposed samples appear smaller
than those in the unexposed samples, where one microscopic field only fits half of a colony. At
the end of the differentiation procedure (day 7), the majority of the cells in the sham treated
control show the typical, cobble-stone-like morphology of DE cells. The exposed cells, however,
show a more spindle-like morphology.
The gene expression analyses are shown in figure 3.14. The trend for the pluripotency markers
is similar for both OCT4A and SOX2 during the whole experiment. Before the induction of
differentiation, the exposed cells show a lower mRNA level of OCT4A and SOX2 than the sham
treated control cells. With ongoing differentiation starting at day 4, the sham treated control
cells show a, even though not significantly, lower mRNA level of OCT4A and SOX2 than that
of exposed samples. The endoderm marker SOX17 is not present in both exposed and sham
treated hESC (H9) cultured in pluripotency maintaining conditions. At day 1 after the depletion
of MEF cells, the mRNA level starts to increase in both samples, reaching its maximum at day 3
and decreasing again until day 7. From day 1 to the end of the experiment, the sham treated
cells show a higher mRNA level of SOX17 than exposed cells. The negative marker for DE
SDF1 shows lower mRNA levels in exposed cells under pluripotency maintaining conditions,
and increases until it reaches its maximum at day 5. In contrast, the mRNA levels for SDF1 in
sham treated cells from day 3 on are always lower than that of exposed cells. The mRNA levels
of AFP, a marker for primed DE indicating differentiation into the hepatic lineage, are fluctuating
without any significant differences or trends.
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Figure 3.13: Morphology of exposed and sham treated hESCs (H9) before (d-2) and after (d7) directed differ-
entiation into DE. The encircled area in the lower left picture indentifies differentiated cells with cobble-stone-like
morphology, while the encircled area in the lower right picture identifies differentiated cells with spindle-like mor-
phology.
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Figure 3.14: mRNA content of pluripotency markers OCT4A and SOX2 on the left side, and of differentiation
markers SOX17, SDF1, and AFP on the right side. Error bars represent the standard deviation of n=3 independent
biological experiments. Statistical significance according to Student’s t -test is indicated with ⋆ for p<0.05 or ⋆⋆ for
p<0.01.
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4 Discussion
There exists a certain risk for the in utero exposure of a developing human embryo. Possible
scenarios of exposure to IR comprise accidental, occupational, diagnostic or therapeutic expo-
sures. The likelihood of unintentional exposure to IR is increased in early stages, when the
pregnancy is not determined yet. Possible consequences of an in utero exposure are pregnancy
loss, malformations, mental retardations, low birth weight and childhood cancer [2]. These
consequences strongly depend on the absorbed dose, the radiation quality, and on the gestation
period. Current risk estimates and recommendations for dose limits rely on animal experiments
and epidemiological data [9]. The latest recommendations of the ICRP for example suggest a
dose limit of 0.05Gy for deterministic effects following an in utero exposure. In vitro studies
could help to answer open questions concerning the molecular response of the early human
embryo towards IR. hESCs are frequently used as a model system to investigate the very early
human development. Isolated from the ICM of about five days old embryos they mimic the
blastocyst stage, and they are able to recapitulate early developmental processes [102, 103].
Pluripotent stem cells are furthermore used to test the embryotoxic potential of external agents
such as drugs or chemicals [104, 105]. This study investigated the effect of IR on hESCs in
order to contribute to a better understanding of the IR-effects on early human embryonic devel-
opment. Based on the current literature [69, 73, 62] as well as on previous studies with mouse
ESCs [97], it is hypothesized that hESCs are capable to efficiently exclude IR induced damage
from the population, either via apoptosis or high fidelity DNA repair. Since ESCs give rise to a
whole organism, the need for a proper maintenance of an undamaged population is bigger than
for differentiated somatic cells. Surviving hESCs should then be able to maintain a pluripotent
state and then differentiate appropriately upon any given stimulus.
4.1 A G2 cell cycle arrest and a radiation quality dependent increase of apoptosis mark
the early radiation response of hESCs.
IR is known to induce cell cycle alterations as well as cell death [10]. The level of induced
apoptotic activity as well as cell cycle kinetics and a possible arrest, however, can differ among
cell types. To investigate the effect of IR on cell viability and cell cycle progression, the cell cycle
profile as well as apoptosis were measured after exposure.
Characterizing studies of the hESC (H9) cell cycle revealed a cell cycle duration of 16 to 20 h
(see section 3.3 and figure 3.4), and a distribution of 36% of cells in G0/G1, 41% of cells
in S and 19% of cells in G2/M phase (see section 3.4). The cell cycle duration found in this
study is in line with published data, where a cell cycle duration of 16-20 h with variations up
to 25% is reported [60, 61] (see also section 1.5.3). The cell cycle distribution for hESCs (H9)
as reported by [60] comprises a smaller fraction of cells in G0/G1 phase (19%) and a bigger
fraction of cells in S phase (66%) than what was observed in this work, while the fraction
of cells in G2/M phase is very similar (16%). The variance of cells in G1 phase might stem
from spontaneous differentiation occurring in the cultures. While most differentiating colonies
can be excluded during manual passaging (see figure 2.1 and 3.2), enzymatically passaged
cultures might accumulate varying fractions of differentiated cells. In the study performed by
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Becker et al. [60], cells were entirely passaged enzymatically, while in this study, parts of
the experiments were performed using manually passaged cells. A longer duration of the G1
phase would indicate that cells have been partially differentiated as differentiated somatic cells
exhibit a longer G1 phase than true pluripotent ESCs(see also section 1.5.3). Indeed, cells that
were passaged manually and therefore are supposed to harbor less spontaneously differentiating
cells showed a smaller fraction of cells in G1 phase of only 20%. Interestingly, the fraction of
unexposed cells in G2 phase was elevated 7 h after exposure compared to later time points.
This might be due to a slight G2 block, that was induced even in control cells possibly as a
consequence of temperature variations during the first medium exchange at 0 h.
Analyzing the cell cycle distribution of irradiated samples revealed an elevated fraction of
cells in G2/M phase, indicating a radiation induced arrest in G2 phase. No cell cycle block at
any other cell cycle check point was observed. A lack of checkpoints other than the G2 cell cycle
checkpoint has already been reported by [78] in response to γ-rays, and was also observed for
X-rays and heavy ions in this study. The G2 block was overcome by the majority of surviving
cells after 24 h. Sokolov and colleagues [87] performed a similar experiment with hESCs (H9)
exposed to 1Gy of X-rays. The fraction of cells in G2 phase reported in their study, e.g. 29%
before exposure, 47% at 4 h, decreasing to 36% at 24 h after exposure, is in good accordance
with the experiment of 1Gy X-ray exposed enzymatically passaged hESCs (see figure 3.5A2) and
confirms a duration of approximately 24 h for a 1Gy X-ray induced G2 block. A dependence of
the G2 block on the radiation quality was not observed, even though this is frequently reported
in in vitro experiments, and has also been observed in previous experiments with mouse ESCs
[97]. An additional time point prior to the 7 h one could elucidate a possible radiation-quality
dependence for the cell cycle arrest in G2 phase.
Besides an IR induced G2 block, hESCs are known to be very sensitive to DNA damage in-
duced apoptosis due to constitutively available active BAX and a mitochondrial primed state
(see section 1.5.3). Section 3.5 describes the results of IR induced apoptosis in hESCs (H9).
The background level of apoptotic cells in enzymatically passaged control samples was five
times lower than that of the manually passaged control. Even though one has to be careful with
an interpretation of this high difference between enzymatically and manually passaged controls
due to the low sampling numbers (nenzymatically=10 and nmanually=1), this result might suggest
that the sensitivity for radiation induced apoptosis decreases in enzymatically passaged and
therefore more heterogeneous samples. This is another indication for the occurrence of differ-
entiated cells in the enzymatically passaged culture as apoptosis is not their primary response to
cell damaging impacts. Further experiments support the idea of the radio sensitivity depending
on the passaging method: While enzymatically passaged hESCs were successfully cultivated up
to seven days following an exposure to 3Gy X-rays (see figure 3.12), this was not possible for
manually passaged hESCs (data not shown) since most of the cells died in the first 72 h after an
exposure to ≥2Gy X-rays.
The experimental results shown in figure 3.7 confirm the high apoptotic rate not only for
hESCs exposed to sparsely IR as already reported by [78, 80, 85, 86], but also for heavy ion
radiation, which has not been demonstrated before. The facilitated cell death (see section
1.5.3) compared to differentiated somatic cells allows an efficient exclusion of damaged cells
from the pluripotent population that will later give rise to a functional organism. Even though
massive apoptosis was observed, i.e. >50% in case of 1Gy Ca ion exposed hESCs at 48 h (see
also figure 3.6 showing an image of massive apoptosis in 1Gy X-ray exposed cells after 24 h
54
compared to control), “patchy regions” as reported by others [80, 78] did not occur in any of
the samples.
The high sensitivity for IR induced apoptosis together with an IR induced cell cycle arrest
might have dramatic consequences for an in vivo exposure of the early, blastocyst stage embryo.
Since the early embryo follows a temporally and spatially highly regulated developmental pro-
cess in the peri-implantation period, a disturbance of this process could prevent an implantation
of the embryo. This is also reflected in figure 1.1, in which prenatal death as a result of implan-
tation failure as the main outcome for that developmental period after in utero exposure to IR
is predicted.
4.2 Surviving hESCs efficiently maintain a population with hardly any chromosomal
aberrations and only few transmissible translocations.
To investigate the IR sensitivity for chromosomal damage of hESCs, and their ability to maintain
an aberration free population, mFISH was performed in first mitotic cells as well as in the
progeny after more than 16 divisions.
The cytogenetic analysis of chromosomal aberrations in hESCs (H9) (see section 3.7) revealed
an extremely low spontaneous aberration yield, i.e. an average fraction of aberrant cells in all
unexposed samples of 0.004±0.002. Data from a previous study in mouse ESCs showed a
spontaneous aberration yield with a fraction of aberrant cells of 0.07. According to Stambrook
and colleagues, the mutation frequency according to a HPRT mutation assay is 100 fold lower
in mESCs compared to MEFs [106]. In this study, the observed spontaneous aberration yield
in hESCs is even lower than what was observed in mESCs (0.004 versus 0.7), speaking for
a better DNA repair system and/or better DNA damage control in human ESCs compared to
mouse ESCs and differentiated cells. The study by the International Stem Cell Initiative reports
a significantly higher frequency of aberrant cells in enzymatically passaged cultures compared
to manually passaged cultures [61] (see section 1.5.3). However, as the study does not state any
passage number, the results are difficult to interpret. In our study, no difference in the fraction
of aberrant cells between manually and enzymatically passaged cultures was observed.
After exposure to IR, the fraction of aberrant cells was induced in a radiation quality-
dependent manner, rising up to 0.25 in 1Gy Ca ion exposed cells and 0.14 in 1Gy X-ray
exposed cells at 20 h post exposure. At this early time point, the majority of cells was still
in the first mitosis (see also section 3.3). However, it has to be kept in mind that there are three
aspects that may lead to an unbalanced underestimation of the yield of aberrant cells within the
samples, especially at this early time point 20 h after exposure. First, due to the asynchronous
nature of the cell population a subset of cells might not reach mitosis at the time of the first
chromosome harvest irrespective of the IR . Second, a large portion of the cells is eliminated via
apoptosis in a radiation-quality dependent manner before the 20h time point. Third, depending
in the radiation quality, some cells may stay in the abovementioned G2 cell cycle block and not
reach first mitosis 20h after exposure. Using premature chromosome condensation (PCC), by
which chromosomes can be harvested independent of natural mitosis, these challenges could be
overcome [107]. The fraction of aberrant cells decreased with time. Four days after exposure,
the majority of the cells has undergone more than four cell divisions. Therefore, henceforward
no initially damaged cells but the surviving progeny was observed. At this time point, the frac-
tion of aberrant cells in both densely and sparsely IR exposed samples converged to the level
of the control, suggesting an efficient exclusion of aberrant cells from the population, which
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possibly might be the result of special repair characteristics (see section 1.5.4) and an elevated
apoptotic activity (see section 3.5 and figure 3.7). More than 14 days after exposure, the C ion
exposed sample still exhibited a few chromosomal aberrations, that mainly consist of transmis-
sible translocations (two reciprocal translocations and three either true non-reciprocal or small,
terminal translocations). However, the frequency of aberrations in this sample was not signif-
icantly different to the Ca ion and X-ray exposed samples at 4 days, indicating that no de novo
aberrations or genetic instability was induced. To confirm this observation and to investigate
whether the densely IR induced frequency compared to controls remains elevated or further
decreases at more than four days after exposure, additional time points for the same ion species
and energy should be added covering an extended period of time. High LET radiation is known
to induce a broader distribution of the number of aberrations per cell, and to induce more com-
plex aberrations than sparsely IR [108, 109]. This is due to the fact that ionizing events in
case of high LET radiation such as Ca or C ions cluster locally along the particle track, while
in case of low LET radiation such as X-rays, ionization events are homogeneously distributed in
the target sample (see also section 1.2). In hESCs (H9), a broader distribution of the number
of aberrations per cell in case of heavy ion exposed cells was observed at all three time points,
20 h, 4 days and 14 days (data not shown). The number of complex aberrations is not signifi-
cantly different between heavy ion irradiated and X-ray exposed samples. However, this might
just be due to the fact that there were only very few complex aberrations observed in general,
e.g. one complex aberration in 40 scored hESCs (H9) at 20 h after exposure to 1Gy Ca ions. A
bigger sample size would be necessary to clearly recognize the fingerprint of high LET radiation
in terms of complex aberrations. The complexity of the few complex aberrations decreases in
a time-dependent manner. As highly complex aberrations are mostly non-transmissible [108],
they are observed only in first mitotic cells. Consequently, only transmissible complex aberra-
tions with lower complexity compared to first mitotic cells are observed in the progeny, while at
later time points after more than 16 cell divisions, no complex aberrations were found.
In a previous study with mouse ESCs, it was found that 38 additional aberrant cells per 100
cells scored were induced in first mitotic cells by 2Gy X-rays, which decreased down to 6 aber-
rant cells per 100 cells scored above background level after 8 days. In contrast, only 25 aberrant
cells per 100 cells scored were induced in first mitotic cells even by high LET radiation (1Gy
Ca ions), that decreased down to 5 aberrant cells per 100 cells scored only after 4 days. This
comparison suggests a lower number of radiation induced aberrant cells and a faster decrease of
the fraction of aberrant cells in human compared to mouse ESCs. In vivo studies corresponding
to the ESC stage (pre-implantation embryos) are rather scarce. A study by Weissenborn and
Streffer [110, 111] reports on the effect of X-ray irradiation on the chromosomal integrity of a
2-cell mouse embryo. They found a slightly higher frequency of aberrations per first mitotic cells
than what was found in hESCs in this study (0.3 aberrations/cell after 0.9Gy X-rays versus 0.2
aberrations per cell after 1Gy X-rays in hESCs). Future experiments investigating the relation
between IR induced chromosomal aberrations in blastocyst-stage embryos, mouse, and human
ESCs (in vivo versus in vitro) could provide the basis to correctly extrapolate in vitro data to in
vivo exposure scenarios.
Due to the technical challenges, incomplete, broken metaphases were present in all samples
impeding the analysis of numerical aberrations. However, trisomies that are known to provide
growth advantages in hESC cultures and that are related to cell culture techniques (like trisomy
20, see section 1.5.3) have not been observed in any of the samples, speaking for the good
quality of the initial cell population.
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4.3 hESCs exposed to IR exhibit alterations in key signaling pathways, leading to a
downregulation of pluripotency markers and a less efficient differentiation into
definitive endoderm.
To investigate IR induced gene expression alterations in embryonic signaling pathways that in-
fluence the potency of hESCs (see section 1.5.2), the mRNA content of 84 genes was analyzed
using the Human Stem Cell Signaling PCR Array (see section 2.9). The two clustergrams in fig-
ure 3.11 show that in case of enzymatically passaged cultures of hESCs, neither a co-clustering
of exposed samples nor of controls occurs. In contrast, manually passaged cultures cluster
together depending on exposure conditions, and the number of significantly altered mRNAs is
higher than in any other enzymatically passaged sample group (see figure 3.12A). This indicates
that the heterogeneity in enzymatically passaged cultures, i.e. a mixture of pluripotent hESCs
and spontaneously differentiating cells, leads to a high biological variability in gene expression
studies and therefore a certain background noise, that masks significant differences of mRNA
content between exposed and unexposed hESCs. Therefore, it is important to adapt the culture
conditions of hESCs in a way that provides an initial cell culture with an absolute minimum of
spontaneous differentiation that otherwise might disguise important conclusions of any given
ESC study.
The following section provides a more detailed discussion of the signaling alterations observed
in hESCs exposed to IR, as shown in figure 3.12A. The enzymatically passaged cultures exposed
to 3Gy X-rays and analyzed 24 h later showed eight mostly downregulated genes compared
to their sham treated control. Most of these genes are involved in TGFβ signaling and indi-
cate a downregulation of this pathway, that is normally responsible for preserving pluripotency
in hESCs (see section 1.5.2). Also, an FGF receptor that is important for the maintenance of
pluripotency, was significantly downregulated. Only one of 25 genes (TCF7) tested that are
involved in WNT signaling showed a significantly different, i.e. higher amount of mRNA in ex-
posed samples compared to the control. The effect of an active WNT pathway depends on other
interacting factors. In the absence of downstream signals of FGF and Activin signaling, whose
receptors were downregulated in the exposed samples, WNT signaling promotes differentiation
instead of self renewal [49]. Taken together, enzymatically passaged hESCs (H9) analyzed 24 h
after exposure to 3Gy X-rays showed a downregulation of pluripotency maintaining pathways.
However, at this time (24 h), the cell population consisted of a mixture of surviving cells, and
cells that undergo apoptosis (see section 3.5). Therefore, it was of interest whether the down-
regulation of pluripotency supporting signaling pathways persists at a later time point, e.g. 7
days, or if this effect would be compensated after excluding damaged cells from the popula-
tion via apoptosis. Seven days after exposure to 3Gy X-rays, the surviving cells still exhibited a
downregulation of TGFβ signaling, even though it is not the same genes than the ones downreg-
ulated 24 h after exposure. Also, the significantly lower mRNA content of another FGF receptor
indicates a persistent downregulation of FGF signaling, and a significantly lower mRNA content
of six WNT signaling-promoting genes shows a clear downregulation of the WNT pathway. Addi-
tionally, Notch signaling and Hedgehog signaling were downregulated, but there is no detailed
understanding of the interaction of these two specific pathways in relation to cell potency. Taken
together, these results speak for a persisting downregulation of embryonic signaling pathways
in hESCs (H9) exposed to sparsely IR, predisposing them to spontaneous differentiation instead
of maintaining the pluripotent state.
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In enzymatically passaged hESCs exposed to densely IR (3Gy Ti ions, LET=107 keV/µm), all
six signaling pathways represented on the array were partially affected, resulting in both an
up- and downregulation of genes. The majority of significantly differentially expressed genes
promoted pluripotency. However, it has to be kept in mind, that the statistical significance of
differentially regulated genes in the exposed sample compared to its sham treated control in
this experiment is based only on technical triplicates instead of the more informative biological
triplicates. Therefore, drawing a clear conclusion is difficult due to the many differentially
affected pathways and might be misleading due to the unrepresented biological variability.
The largest number of significantly differentially expressed genes was found in manually pas-
saged cultures due to the reduced heterogeneity in the initial cell culture. Since reduced hetero-
geneity in manually passaged cultures also results in a higher radiosensitivity (see section 4.1),
the dose of 3Gy applied in the previous X-ray experiment with enzymatically passaged hESCs
had to be reduced to 1Gy. The results captured at 24 h after exposure show that all six path-
ways represented on the array were downregulated. This results in an impaired maintenance
of pluripotency, favoring spontaneous differentiation instead. The results of the previous X-ray
experiment are confirmed.
Taken together, the investigation of IR induced embryonic signaling alterations reveals a
strong and persistent downregulation of embryonic pathways like WNT, TGFβ, FGF, Notch and
Hedgehog signaling in hESCs (H9) exposed to X-rays. Consequently, cells are predisposed to
spontaneous differentiation at the expense of pluripotency. Assessing the reason for the down-
regulation of embryonic signaling pathways was not subject of this work. There are only few
publications studying DNA damage induced alterations in embryonic signaling in ESCs, and
these concentrate mainly on WNT signaling. A study performed by Carreras-Puigvert and col-
leagues reports about a cisplatin induced, p53 independent, Wnt signaling in mouse ESCs, which
has a protective effect increasing the cell viability [112]. In contrast, Lee and colleagues report
about an UV induced p53 dependent upregulation WNT ligands [113]. They suggest a model
in which DNA damage induces active p53, which leads to differentiation or cell death in order
to exclude the damaged cell from the pluripotent population. Simultaneously, p53 leads to an
increased WNT secretion that leads to self renewal and maintenance of pluripotency in neigh-
boring, undamaged cells. However, cisplatin is a crosslinks inducing chemotherapy drug, and
UV light is mainly inducing thymdin dimers, which are both leading to different DDRs compared
to IR. Therefore, future experiments are necessary to elucidate how IR induced DDR in hESCs
can lead to a downregulation of embryonic signaling pathways.
Analyses of pluripotency and differentiation markers via flow cytometry and qPCR confirm the
hypothesized consequences of the downregulated embryonic signaling pathways after expo-
sure to IR. Figure 3.8 shows an increase of enzymatically passaged hESCs (H9) positive for
the differentiation marker SSEA1 up to 50 h after exposure to 1Gy X-rays and 1Gy Ni ions
(LET=174 keV/µm). The pluripotency marker SSEA4 does not seem to be affected though.
However, SSEA4 might simply not be the right marker for investigation of IR affected pluripo-
tency, consisting of a huge interacting network that provides many more markers with different
kinetics concerning their radiation dependent expression. Indeed, the qPCR analysis of two core
transcription factors in the pluripotency network of manually passaged hESCs (H9) showed a
significant downregulation two days after exposure to 1Gy X-rays: Figure 3.14 depicts a 50%
lower mRNA content of OCT4A and a 36% lower mRNA content of SOX2 in exposed samples
compared to sham treated controls. The downregulation of core pluripotency transcription fac-
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tors such as NANOG and OCT4 has been reported in response to UV induced DNA damage in
a p53 dependent manner [74]. As p53 is also induced in response to X-ray and ion irradia-
tion induced DNA damage, one can assume a p53 dependent downregulation of the pluripotent
circuitry in this study, including OCT4A and SOX2. Despite this crucial effect of IR on the cell po-
tency, morphological changes of hESCs (H9) were not yet observed, except for a smaller colony
size in exposed samples (see figure 3.13).
To investigate the functional consequences of the IR effect on cell potency, exposed and sham
treated hESCs (H9) were directly differentiated into DE, one of the three germ layers that will
give rise to the gastrointestinal tract, liver, pancreas and other associated visceral organs. In the
first 24 to 48 h after exposure but before initiating directed differentiation, hESCs (H9) already
showed alterations in gene expression that compromise the requirement, i.e. initial pluripo-
tency, for an efficient differentiation into DE. As already discussed, the cells exposed to 1Gy of
X-rays showed a lower level of mRNA for pluripotency markers OCT4A and SOX2 (see figure
3.14), implying a predisposition of the cells for a spontaneous differentiation into their pre-
ferred, not necessarily DE, cell lineage. Additionally, they showed a downregulation of the five
type I and type II Activin receptors (see clustergram for manually passaged cultures in figure
3.11) 24 h after exposure. The Activin receptors are necessary for a directed differentiation into
DE, since a continuous supply of high concentrations of Activin A as a surrogate of NODAL (see
also section 1.6 and figure 1.6) ensures that the differentiation of the cells is forced towards the
DE lineage. The downregulation of the Activin receptors indicates an impaired differentiation
capacity into DE. Indeed, the observation of the DE marker pair SOX17high/ SDF1low during
the differentiation process until day 7 showed an impaired differentiation efficiency of cells ex-
posed to 1Gy X-rays compared to their sham treated control. While unexposed cells showed a
DE-typical pattern of high SOX17 mRNA content, especially from day 3 to day 5 and low SDF1
mRNA content, irradiated cells showed a lower SOX17 and a higher SDF1 mRNA content. Since
the absence of SDF1 mRNA together with high SOx17 content accounts for DE, and the presence
of SDF1 mRNA together with SOX17 mRNA accounts for extraembryonic endoderm (see also
section refSec Results DE), the expression pattern of this marker pair in exposed cells might indi-
cate a mixture of differentiating cells among which DE and extraembryonic lineages are present.
Additionally, the pluripotency markers OCT4A and SOX2 were downregulated in control cells
during DE differentiation as expected, but in cells exposed to IR, the downregulation of these
core pluripotency markers was less efficient. Due to the irradiation, the cells have might have
differentiated prematurely rendering them not responsible to the DE inducing factors. Whether
the irradiation changes the differentiation preferences of ESCs has to be further elucidated. The
predisposition of hESCs towards a certain cell lineage not only depends on the culture condi-
tions, but also on the cell line itself [114]. Preliminary experiments by I. Schroeder at GSI show
an increased fraction of hESCs (H9) that develop into beating cardiomyocytes after exposure
to sparsely IR compared to their sham treated control. This would suggests a predisposition of
irradiated hESC (H9) for the mesodermal lineage.
So far, previous studies did not detect any IR induced alteration of pluripotency in ESCs.
Neither mESCs showed a differential expression of OCT4 and SOX2 17days after 0.5 to 3Gy X-
rays and C ions [97], nor did hESCs (H9) show significant differences in OCT4, SOX2 or NANOG
expression 24 h after 0.4 to 4Gy of γ-radiation [80] or up to 65 h after 0.2 to 1Gy γ-radiation
[85] (see section 1.5.4). This is the first study that reports a profound alteration of cell potency
in hESCs after exposure to X-rays.
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4.4 Conclusion and outlook
It was hypothesized that hESCs that serve as a model for early human embryonic development
respond to IR by either high fidelity DNA repair or by apoptosis to efficiently exclude damaged
cells from the population (see section 1.7). Consequently, surviving cells should be cytogeneti-
cally healthy and able to maintain pluripotency in order to give rise to a functional organism. In
this study, it was found that hESCs exposed to IR exhibit a radiation quality dependent frequency
of initially damaged cells. Consequently, cells arrest in G2 phase of the cell cycle, presumably
to repair the radiation induced damage. A fraction of hESCs eventually undergoes facilitated
apoptosis (see also section 1.5.3), which enables them to efficiently exclude damaged cells from
the population. However, surviving hESCs do harbor cytogenetic aberrations in case of high
LET radiation, and show altered gene expression levels, in contrast to the initial hypothesis
suggesting that surviving hESCs maintain their initial characteristics. The residual chromoso-
mal aberrations mainly comprise transmissible translocations; IR induced cytogenetic instability
was not observed. For the first time, it was shown that hESCs exhibit a loss of pluripotency
after exposure to X-rays, which is in contrast to what was reported in literature up to now (see
also section 4.3). Interestingly, it was found that a culture system that minimizes the events
of spontaneous differentiation in the population, e.g. manually passaging, is crucial to allow
the detection of effects on hESCs, that are not hidden by the heterogeneity of a poorly cultured
population.
The results reported in this work might indicate several consequences for the early embryo
in case of an in utero exposure. The radiation induced G2 block together with a high sensitiv-
ity for IR induced apoptosis might lead to a disturbance of the spatially and temporally highly
regulated developmental process and to a reduction of the cell number in the pre-implantation
embryo. Thus, the early embryo might fail to implant, leading to pregnancy loss. This provides
a possible explanation for the predictions of in utero irradiation illustrated in section 1.7. Fur-
thermore, the IR induced alterations in gene expression do influence the developmental process
of the early embryo. Assuming that the effect of IR on gene expression and signaling pathways
is a linear-non-threshold effect, and the dose is low enough to not disturb the implantation in
the uterus, alterations in signaling pathways leading to further alterations in cell differentiation
would still occur. Thus, the pregnancy would continue, but alterations in developmental pro-
cesses are possible, eventually leading to severe malformations.
Future experiments could help to elucidate underlying mechanisms or the radiation response
of hESCs, thereby potentially improving radiationn risk assessment for an in utero exposure. For
example, the analysis of pluripotency markers and differentiation markers as described in sec-
tion 3.6 and 3.9 was only performed with X-rays and should be repeated with hESCs exposed to
densely IR, like therapy relevant C ions. As the mechanisms underlying the biological response
towards sparsely and densely IR might be completely different, it is important to understand
if the results observed for X-rays are different for isodoses of C ions. Also, it is of interest to
clarify the mechanisms behind the signaling alterations in response to IR, that lead to the im-
paired potency state of hESCs. Therefore, an additional experiment could be performed, that
investigates the upstream targeting contributors of embryonic signaling pathways. For example,
a possible connection between upregulated DNA repair pathways or the increase of active p53
and downregulated signaling pathways represents a valuable subject of investigation. Other
possible mediators that are responsible for a downregulation of embryonic signaling pathways
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in hESCs could be miRNAs, that are known to inhibit the translation of other proteins. An-
other important experiment in addition to the differentiation capability into DE described in
this study (see section 3.9) would be the effect of IR on the differentiation capability into meso-
dermal and ectodermal lineages. This would complete the differentiation capability studies
concerning all three germ layers, and could reveal a possible predisposition of hESCs (H9) in
case of spontaneous differentiation. A predisposition for spontaneous differentiation of hESC
lines was already described by [114], and preliminary experiments by I. Schroeder at GSI sug-
gest a possible predisposition for hESCs (H9) into the mesodermal lineage. For experiments
focusing on special characteristics of hESCs like the facilitated apoptotsis (see section 1.5.3) or
the lower mutation frequency (see section 1.5.3) compared to differentiated somatic cells, it
would be interesting to additionally measure endpoints like Caspase-3 activity or chromosomal
aberrations in parallel to differentiated cells originating from hESCs. A direct comparison of
hESCs and an originating differentiated counterpart is important to avoid inter-experimental
and inter-laboratory differences in case of a comparison with literature data as performed in
this study.
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Appendix
Table 4.1: Cell culture material
Type (and composition if applicable) Manufacturer
DMEM liquid medium with stable glutamine Biochrom
DMEM/F-12, no glutamine, no HEPES Thermo Fisher Scientific
RPMI 1640 Thermo Fisher Scientific
KnockOut™DMEM Thermo Fisher Scientific
KnockOut™Serum Replacement Thermo Fisher Scientific
Non-essential amino acids (NEA) Biochrom
L-alanyl-L-glutamine Biochrom
1 M HEPES buffer (50x) Biochrom
Recombinant Human FGF-basic (in 5mM Tris, 0.01% BSA, pH7.6) Peprotech
Fetal Bovine Serum (FBS or FCS) Merck Milipore
Trypsin 0,05%/EDTA 0,1% in PBS without Ca2+ and Mg2+ PAN-Biotech
PBS solution without Ca2+, Mg2+ (PBS-/-) Merck Milipore
PBS-solution with Ca2+, Mg2+ (PBS+/+) Merck Milipore
Gelatine (0.1% in PBS-/-) neoLab
Matrigel growth factor reduced BD
Dispase BD
Recombinant Human Activin A Peprotech
Recombinant Mouse Wnt-3a Peprotech
DMSO Roth
β-Mercaptoethanol Roth
Tris ultrapure Applichem
BSA Sigma
Penicillin/Streptomycin Biochrom
Table 4.2: H9-medium for enzymatic passaging
H9-medium for enzymatic passaging
DMEM/F12
+ 25% Knockout Serum Replacement
+ 1.875% HEPES
+ 1.25% L-Glutamin
+ 1.25% Non essential amino acids
+ β-mercaptoethanol 100µM final concentration
+ 0.5% Penicilllin/Streptomycin
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Table 4.3: H9-medium for manual passaging
H9-medium for manual passaging
Knockout DMEM
+ 25.7% Knockout Serum Replacement
+ 0.64 % L-Glutamin
+ 1.29% Non essential amino acids
+ β-mercaptoethanol 100µM final concentration
+ 0.64% Penicilllin/Streptomycin
Table 4.4: MEF-medium
MEF medium
DMEM FG0445
+ 10% FCS F
+ 1% Penicilllin/Streptomycin
Table 4.5: Freezing-medium
Freezing-medium
90% FCS F
+ 10% DMSO
Table 4.6: DE-medium
DE-medium
RPMI
+ 50% KO DMEM
+ 1.53% L-Glu
+ 100 ng/ml ActA
+ 0.76% Penicilllin/Streptomycin
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Table 4.7: Chemicals and RNA
Type Composition (optional) Manufacturer
EDTA Roth
Ethanol ROTH
Formaldehyde solution 37% Merck
Triton-X-100 Merck
Vectashield Vector Laboratories
Colcemid Roche
KCl (0.075M in H2O) Merck
Methanol Roth
Acetic Acid Merck
Immersion oil Zeiss Sybr green
RNAse and DNAse free water Qiagen
DAPI Roth
Hoechst 33342 Sigma-Aldrich
5x HOT FIREPol® EvaGreen® qPCR Mix Plus (ROX) Solis Biodyne
human fetal liver whole tissue RNA Clontech
Table 4.8: Primer for individual mRNA expression analysis
Gene Oligo Sequence Manufacturer
POU5F1 sense 5’-ACC CAC ACT GCA GCA GAT CA-3’ biomers.net
POU5F1 antisense 5’-CAC ACT CGG ACC ACA TCC TTC T-3’ biomers.net
SOX2 sense 5’-CAC TGC CCC TCT CAC ACA TG-3’ biomers.net
SOX2 antisense 5’-CCC ATT TCC CTC GTT TTT CTT-3’ biomers.net
SOX17 sense 5’-CCA GAG GCT TTT TGG ATG TTT T-3’ biomers.net
SOX17 antisense 5’-AGG TAA ACT GAA TGT CGA GGA GTG T-3’ biomers.net
SDF1 sense 5’-CGT CAA GCA TCT CAA AAT TCT CA-3’ biomers.net
SDF1 antisense 5’-CAG CCG GGC TAC AAT CTG A-3’ biomers.net
AFP sense 5’-CTG CAA ACT GAC CAC GCT-3’ biomers.net
AFP antisense 5’-TGA GAC AGC AAG CTG AGG AT-3’ biomers.net
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Table 4.9: List of primer sets in the stem cell signaling qPCR array
Pluripotency maintenance pathway
Receptors: IL6ST (GP130), LIF
Transcription Factor: STAT3
FGF signaling pathway
Receptors: FGFR1, FGFR2, FGFR3, FGFR4
Transcription Factor: CDX2
Hedgehog signaling pathway
Receptors and co-receptors: PTCH1, PTCHD2, SMO
Transcription factors and co-factors: GLI1, GLI2, GLI3, SUFU
Notch signaling pathway
Receptors and co-receptors: NCSTN, NOTCH1, NOTCH2, NOTCH3, NOTCH4, PSENEN,
PSEN1, PSEN2
Transcription factor: RBPJL
TGF β superfamiliy signaling pathway
Receptors and co-receptors: ACVRL1, ACVR1, ACVR1B, ACVR1C, ACVR2A, ACVR2B,
AMHR2, BMPR1A, BMPR1B, BMPR2, ENG, LTBP1, LTBP2, LTBP3, LTBP4, RGMA,
TGFBR1, TGFBR2, TGFBR3, TGFBRAP1
Transcription factors and co-factors: EP300, SMAD1, SMAD2, SMAD3, SMAD4, SMAD5,
SMAD6, SMAD7, SMAD9, CREBBP, E2F5, RBL1, RBL2, SP1, ZEB2
Wnt signaling pathway
Receptors: FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, LRP5, LRP6,
VANGL2
Transcription factors and co-factors: BCL9, BCL9L, CTNNB1, LEF1, NFAT5, NFATC1,
NFATC2, NFATC3, NFATC4, PYGO2, TCF7L1, TCF7L2, TCF7
Housekeeping Genes
ACTB, B2M, GAPDH, HPRT1, RPLP0
72
Table 4.10: Kits
Type Manufacturer
MasterPure™RNA Purification Kit epicentre
RT 2 First Strand Kit (12) Qiagen
Human Stem Cell Signaling PCR Array PAHS047Z Qiagen
RevertAid RT Kit Thermo Fisher Scientific
Click-it EdU Alexa 488 Flow Cytometry Kit Invitrogen
FITC Active Caspase-3 Apoptosis Kit BD
BD Stemflow Human and Mouse Pluripotent Stem Cell Analysis Kit BD
24xCyte Human Multicolor FISH Probe Kit Metasystems
RNase-Free DNase Set (50) Qiagen
Table 4.11: Devices
Type Manufacturer
Flowcytometer FACSCanto II BD
Microscope Axio Imager Z1 Zeiss
Thermocycler Primus 96 advanced Peqlab
StepOnePlus™Real-Time PCR System ABI
Cell Counter Casy™1 Schärfe System
Cell Counter TC20™automated BIORAD
Colibri microvolume spectrophotometer Titertek Berthold
X-ray tube Isovolt DS1 Seifert
Dosimeter SN4 PTW
Stereo microscope SMZ-171 Motic
Inverted Light Microscope Eclipse TS100 Nikon
Inverted Light Microscope DM IL Leica
Table 4.12: Software
Type Manufacturer
Metafer4 V3.8.9 Metasystems
Isis V5.5.5 Metasystems
FLOWJO V7.6.5 and V10 FLOWJO, LLC
FACSDiva V7.0 BD
Primer Express V3.0 Thermo Fisher Scientific
StepOne™Software V2.3 ABI
73
Ehrenwörtliche Erklärung
Ich erkläre hiermit ehrenwörtlich, dass ich die vorliegende Arbeit entsprechend den Regeln guter
wissenschaftlicher Praxis selbstständig und ohne unzulässige Hilfe Dritter angefertigt habe.
Sämtliche aus fremden Quellen direkt oder indirekt übernommenen Gedanken sowie
sämtliche von Anderen direkt oder indirekt übernommenen Daten, Techniken und Materialien
sind als solche kenntlich gemacht. Die Arbeit wurde bisher bei keiner anderen Hochschule zu
Prüfungszwecken eingereicht.
Weiterstadt, den
(Sabine Luft)
74
Curriculum Vitae
Personal Data
Contact Sabine Luft
Taunusstraße 7
64331 Weiterstadt
Germany
Date of birth 10/21/1984 in Darmstadt
Education
10/2011 - present PhD student at
GSI Helmholtzcentre for Heavy Ion Research, Department of Biophysics
enrolled at the Technical University of Darmstadt
09/2006-07/2011 Diploma, Biology, at
GSI Helmholtzcentre for Heavy Ion Research, Department of Biophysics
enrolled at the Technical University of Darmstadt
09/2004-07/2006 Commercial training in insurance sales
06/2004 Abitur, Justus-Liebig-Schule in Darmstadt
75
Publications
Peer reviewed
03/2014 The effect of X-rays and C-ions on pluripotent embryonic stem cells;
Luft S., Pignalosa D., Arrizabalaga O., Nasonova E., Helm A., Durante
M., Ritter S.; in Journal of Radiation Research 55(Suppl 1):i55, 2014;
doi: 10.1093/jrr/rrt175
01/2014 Fate of D3 mouse embryonic stem cells exposed to X-rays or car-
bon ions; Luft S., Pignalosa D., Nasonova E., Arrizabalaga O.,
Helm A., Durante M., Ritter S.; in Mutation Research - Ge-
netic Toxicology and Environmental Mutagenesis 760:56, 2014; doi:
10.1016/j.mrgentox.2013.12.004
Scientific reports
10/2014 Preparatory experiments to investigate the radiosessitivity of human
embryonic stem cells; Luft S., Schroeder I., Hessel P., Arrizabalaga O.,
Layer P. G., Durante M., Ritter S.; GSI Scientific Report 2013
05/2013 Influence of ionizing radiation on the potency state of murine embry-
onic stem cells; Luft S., Helm A., Hessel P., Pignalosa D., Brons S., Layer
P.G., Durante M., Ritter S.; GSI Scientific Report 2012
05/2012 Radiation response of pluripotent stem cells derived from early mouse
embryos; Luft S., Helm A., Pignalosa D., Hessel P., Durante M., Layer
P.G., Ritter S.; GSI Scientific Report 2011
Contributions to international conferences
09/2013
Poster
Radiation effects on early embryonic development: Emphasis on gene
expression; Gesellschaft fuer Biologische Strahlenforschung, Jahresta-
gung 2013 in Darmstadt, Germany
05/2013
Oral presentation
The effect of X-rays and C-ions on pluripotent embryonic stem cells;
Heavy Ions in Therapy and Space Radiation Symposium 2013 in Chiba,
Japan
04/2013
Poster
Early and late effects of densely ionizing radiation on mouse embryonic
stem cells; 7th International Meeting des Kompetenznetzwerk Stam-
mzellforschung NRW 2013 in Koeln, Germany
10/2012
Oral presentation
Impact of X-ray and C-ion exposure on mouse embryonic stem cells;
10th International Symposium on Chromosomal Aberrations 2012 in
Amalfi, Italy
76
Danksagung
Für die Unterstützung während meiner Doktorarbeit möchte ich mich recht herzlich bedanken,
besonders bei folgenden Personen.
Prof. Dr. Marco Durante danke ich für die Aufnahme als Doktorandin in seiner Abteilung,
sowie für seine Unterstützung und sein Interesse an meiner Arbeit. Danke für die vielen
wertvollen Ratschläge.
Prof. Dr. Paul G. Layer vom Fachbereich Biologie danke ich für die Übernahme des Koreferats,
sowie für die stets sehr hilfreichen Besprechungen von Versuchsplanungen und Datanenalysen.
Dr. Sylvia Ritter danke ich herzlich für die Aufnahme in der Gruppe der Chromosomen- und
Stammzellfreunde und für Ihre Unterstützung und Ihr Vertrauen in meine Arbeit.
Prof. Dr. Suzanne Kadereit danke ich für die freundliche Anleitung und das Teilhaben lassen
an Ihrer Expertise während der ersten Schritte in der Stammzellkultivierung, sowie für wertvolle
Diskussionen von Experimenten und Ergebnissen.
Dr. Diana Pignalosa und Dr. Insa Schröder danke ich herzlich für die hervorragende Betreuung
und Unterstützung. Ich habe viel von ihnen gelernt.
Petra Hessel, Dr. Elena Nasonova, Dr. Onetsine Arrizabalaga und Dr. Nerea Paz danke ich für
die starke Unterstützung und Expertise beim Durchführen von Experimenten und Chromosom-
enanalysen.
Dr. Alexander Helm danke ich für seine Offenheit und Freundschaft, und seine wertvollen
Ratschläge.
Dr. Thomas Friedrich danke ich für die Unterstützung (inklusive dem Entgegenehmen und
Weiterreichen von wichtigen Telefonanrufen) bei Strahlzeiten, sowie für das Teilen seiner Exper-
tise beispielsweise bei der Berechnung von Fluenzen, Apoptosedaten und Fehlerberechnungen.
Ireen Kuhlish, Giorgia Ciliberti und Simon Frank danke ich für den tollen Einsatz während
der Durchführung sowie Vor- und Nachbereitung von Strahlzeiten.
Anna, Andreas, Till, Maren, Zhan, Walter, Uli, Anke, Bernadette und Francesco danke ich für
ihre Hilfe bei Fachfragen und ihre Freundschaft.
Paul Görgen und Stefan Schulz danke ich herzlich für ihren Einsatz beim Retten meiner LaTeX-
Dateien.
Ich möchte mich bei allen Mitgliedern der Abteilung Biophysik für die freundliche Aufnahme
und Unterstützung bedanken.
Bei HGS-HiRE und FIAS bedanke ich mich für die finanzielle Unterstützung. Diese Arbeit
wurde im Rahmen des Verbundprojektes mit dem Förderkennzeichen 02NUK025 durch das
Bundesministerium für Bildung und Forschung gefördert.
77
78
